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ABSTRACT OF DISSERTATION

TOBACCO-FREE PRISON POLICIES AND HEALTH OUTCOMES AMONG
INMATES
This study was the first to examine the effect of tobacco policies in prisons on the
health of inmates. Kentucky has two types of tobacco policies in its 16 state prisons:
indoor smoke-free policies, where smoking is allowed outdoors and tobacco-free policies,
in which no tobacco of any kind is allowed on the grounds of the prison. The smoking
rate of inmates is three times higher than that of current smokers in the non-incarcerated
population which results in high rates of tobacco-related health conditions such as heart
disease and lung cancer.
A literature review discussed the evolution of tobacco policies in prisons, the
motivations for strengthening policies in prisons and the unintended consequences.
Health outcomes in the non-incarcerated population on the benefits to cardiovascular and
respiratory health following passage of smoke-free laws in public places were reviewed.
No studies have been found on the health outcomes of inmates with varying degrees of
smoke-free or tobacco-free policies.
The first study was a time series analysis comparing the frequency of medication
refills for asthma and/or COPD before and after a tobacco-free policy was implemented.
Short-acting inhaler refills decreased in the first few months following the tobacco-free
policy date but returned to baseline within 12 to 15 months. Rapid turnover of inmates,
minimum security status of the prisons, and possible loosening of enforcement may have
been related to the gradual increase in use.
The second study was a survival analysis on the time to an inmate’s first acute
myocardial infarction (AMI) with tobacco policy status (tobacco-free or smoke-free) of
the prison as the primary predictor variable. Controlling for the multiple movements over
time, facilities, co-morbidities, past smoking history, age and race, there was a 2.87
hazard for AMI for time spent in a smoke-free (indoors) prison compared to a tobaccofree prison. This finding may be due to the fact that tobacco is considered contraband
after prisons become tobacco-free and inmates risk disciplinary action by smuggling or
using tobacco in the prison, thereby reducing secondhand smoke for non-smokers and
probably reducing the consumption of current smokers.
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CHAPTER 1: INTRODUCTION
Tobacco use is the leading cause of preventable death in the world according to
the World Health Organization (WHO, 2006). Tobacco is responsible for 21% of all
deaths in the United States including 89% of all lung cancer deaths. Rates of current adult
smoking prevalence have decreased in the United States over the past 12 years from
24.7% in 1997 to 20.6% in 2009 (CDC, 2010). Inmates, however, smoke tobacco at
higher rates than the general population. Estimates of the current smoking rate among
male and female inmates range from 42% to 91% with an average of 70% to 74%
(Cropsey, Eldridge, & Ladner, 2004; Connell, Winter, & Curd, unpublished, 2007).
Compared to the non-incarcerated population, inmates tend to be of lower socioeconomic
status, have fewer years of education, and are more likely to exhibit high-risk behaviors
such as drug abuse including intravenous drug use. Higher levels of secondhand smoke
(SHS) exposure have been reported in homes of people with lower incomes and among
non-Hispanic blacks (MMWR, 2008). Further, few inmates have health insurance when
not incarcerated. On average, only 15% of inmates report having health insurance in the
year before or after incarceration (Wang, et al., 2009). These factors increase the
likelihood for chronic disease among the inmate population.
In state prisons the leading causes of death are heart disease and cancer, consistent
with the top two causes of mortality in the United States (Mumola, 2007; Xu, Kochanek,
Murphy, & Tejada-Vera, 2010). Over half of the deaths among inmates are caused by
heart diseases (27.3%) and cancer (23.3%) (Mumola, 2007). Lung cancer is the most
common cancer in inmates and was responsible for one in three cancer deaths in state
prisons in 2004 (Mumola, 2007). These diseases are caused by both firsthand tobacco use
and exposure to SHS. In the non-incarcerated population, SHS is estimated to cause
between 57,800 to 97,700 AMIs annually and between 33,500 and 56,900 deaths from
coronary heart disease per year (Lightwood, Coxson, Bibbins-Domingo, Williams, &
Goldman, 2009).
Due to the research on the physically harmful effects of cigarette smoking and
SHS, there has been a gradual increase in the strength and number of smoke-free laws in
communities, states, and countries. The majority of these laws prohibit smoking in indoor
public places and/or workplaces. Local, state, and federal prisons and jails have also
1

adopted smoke-free policies, sometimes secondary to indoor smoke-free laws covering
all state buildings. Within prison systems there is a continuum of restrictions, from
smoke-free indoors only to tobacco-free throughout the entire prison. These policies have
been adopted primarily because of the effects on health and health care costs from
tobacco-related disease.
Health of inmates and secondhand smoke exposure in prisons
The provision of health care for inmates has been federally mandated since 1976
when a Supreme Court ruling determined that the government has an “obligation to
provide medical care for those whom it is punishing by incarceration”("Estelle v.
Gamble," 1976) p. 2). Failure to do so violates the Eighth Amendment proscription
against cruel and unusual punishment since inmates do not have the liberty of obtaining
health care elsewhere. The key summary statement from Estelle v. Gamble that has since
been upheld in cases brought by inmates who were exposed to SHS is that “deliberate
indifference to serious medical needs of prisoners constitutes the unnecessary and wanton
infliction of pain” (p. 103). In Helling v. McKinney, the Court determined that
McKinney’s exposure to SHS by his cellmate and other inmates’ smoking posed an
unreasonable risk to his health, both present and future that constituted “deliberate
indifference” by prison officials to standards that society considers as decent ("Helling v
Mckinney," 1993).
Litigation related to SHS exposure (Sweda, 2004) plus an increasingly convincing
body of evidence of the known harms from smoking and SHS (USDHHS, 2006) have
provided impetus to correctional departments to adopt smoke-free or tobacco-free
policies. The Surgeon General of the United States determined that there is no safe level
of SHS and that separating smokers from non-smokers in indoor spaces cannot eliminate
non-smokers’ exposure to SHS (USDHHS, 2006). The cost of health care for tobaccorelated diseases among inmates and employees, representing approximately 12% of
prison expenditures and has been cited by correctional administrators as one of the
primary reasons for adopting smoke-free policies (Kauffman, Ferketich, & Wewers,
2008; Stephan, 2004).
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Implementation of tobacco-free policies in prisons
Smoke-free policies in prisons vary on a continuum from designated smoking
areas indoors; to no indoor smoking with outdoor smoking allowed; to comprehensive
smoke-free or tobacco-free policies in which smoking or all tobacco products are
prohibited in all indoor and outdoor places. The majority of State Departments of
Corrections and the Federal Bureau of Prisons have indoor smoke-free policies (FBOP,
2004). Tobacco-free policies, in which no tobacco products are allowed on the grounds of
the prison, indoors and out, are increasing in prevalence (ANRF, 2010). These tobaccofree policies often include smokeless and spitless tobacco (e.g., snus) and sometimes also
prohibit nicotine replacement products.
The inherent challenge in reducing tobacco use in prisons by implementing
tobacco-free policies is that tobacco is not only an addictive product to be smoked,
chewed, sniffed, or placed between the lip and gum but it also is the inmates’ informal
currency (Lankenau, 2001). Inmates are not permitted to have cash and earned income
from working in the prison is monitored in an account managed by the prison staff and
inmates can access it to buy goods from the prison commissary. Tobacco becomes a
durable form of currency which is often used to barter or buy services, bribes, or other
favors As restrictions on tobacco use or access to the product increase with more
restrictive prison policies, the real price of tobacco increases (Garland, 2006; Johnson,
2010).
The security status of the prison (minimum, medium, or maximum) may be
related to the proportionate value of tobacco. Minimum security prisons have fewer
physical restrictions such as barbed wire fences or guard towers, allowing greater access
to the outside. Also, inmates in minimum security prisons frequently work away from the
prison on work-release programs which allow greater access to tobacco even if the prison
is ostensibly tobacco-free. Even in medium security prisons with tobacco-free policies,
many smokers find ways to continue smoking after tobacco is officially prohibited
(Proescholdbell, Foley, Johnson, & Malek, 2008).
Another challenge in implementing tobacco-free prison policies and studying
their effects is that prisons do not house a stable population of inmates compared to the
non-incarcerated population who typically reside in the same community over time.
3

Ninety-five percent of inmates are eventually released from prison. In 2008, there were
739,132 inmates admitted and 735,454 inmates released from state and federal prisons
(Sabol, West, & Cooper, 2009).
Health outcomes and smoke-free policies
Studies with non-incarcerated populations have reported improvements in
cardiovascular and respiratory health following passage of legislation prohibiting
smoking in indoor public places and workplaces. The primary outcome measure in the
literature is acute myocardial infarction (AMI), which has valid and reliable diagnostic
criteria. Respiratory symptoms have also been measured as health outcomes but these are
typically self-report data. Some studies have used emergency department visits for
asthma as a proxy marker of respiratory health (Rayens, et al., 2008). To date, there have
been no published health outcome studies of tobacco-free prison policies, although there
have been a few air quality monitoring studies in prisons before and/or after
implementation of these policies (McGuire & Connell, 2010; Proescholdbell, et al.,
2008).
Study population: Kentucky Corrections Health Services Network
The Kentucky Department of Corrections (KY DOC) is one of a few state
systems to have partnered with a university to assist in managing the health care of its
inmates. In 2003, the KY DOC joined with the University of Kentucky to create a publicprivate partnership called the Kentucky Corrections Health Services Network (KCHSN).
The three KCHSN partners are the KY DOC, the University of Kentucky, and
CorrectCare Integrated Health, Inc, a for-profit health management company. The
KCHSN partnership established a health services network to provide medical care to
inmates incarcerated across the state and to contain costs while at the same time
improving quality of care. In addition, health care-related data (costs and related data on
hospitalizations and specialty consults) are tracked electronically by CorrectCare and can
be linked to patients, providers, and facilities. The KCHSN implemented an electronic
health record (EHR) that allows access to the medical status, history, and medication
record of each inmate. There is one pharmacy vendor, Diamond Pharmaceutical, for the
4

state that receives medication orders directly from providers via the EHR. Diamond data
is tracked electronically and can be reported by inmate identification number, by drug, or
disease state. This research was facilitated by having centralized databases that track the
health care of all Kentucky inmates in state prisons.
Purpose of the dissertation
This dissertation research was designed to evaluate the effects of two different
tobacco policies on respiratory and cardiovascular health indicators in Kentucky State
prisons The overarching policy for the KY DOC prisons is an indoor smoke-free policy
(smoking allowed outdoors) but there are five KY DOC prisons that have adopted a
tobacco-free policy in which no tobacco products are allowed on the grounds of the
prisons including nicotine replacement products. It was hypothesized that greater
improvements in respiratory and cardiovascular health outcomes would occur over time
in inmates housed in a tobacco-free prison environment than those in a prison with an
indoor smoke-free policy.
Overview of Chapters Two through Five
Chapter Two is an integrative review of the evolution of smoke-free and tobaccofree policies in correctional systems and the benefits and unintended consequences of
these policies. Research on health outcomes following passage of smoke-free legislation
in the non-incarcerated population is discussed. There are no studies on the effects of
smoke-free or tobacco-free prison policies on the health of inmates.
Chapter Three describes a time series analysis of secondary data examining the
effects of the implementation of a tobacco-free policy on respiratory health using
medication refills for asthma and/or COPD as a proxy marker. The purpose was to
evaluate the effect of a tobacco-free prison policy compared to an indoor smoke-free
policy (smoking is allowed outdoors) on the respiratory health of inmates with asthma
and/or COPD. It was hypothesized that due to expected reductions in the rate of current
smoking and subsequent SHS exposure in tobacco-free prisons, inmates would use fewer
medications for asthma and/or COPD following the implementation of the tobacco-free
policy compared to those residing in smoke-free prisons.
5

Chapter Four describes a survival analysis of secondary data that evaluates the
hazard ratio for having an AMI in a smoke-free prison compared to a tobacco-free prison.
It was hypothesized that there would be an increased hazard for AMI in smoke-free
prisons versus tobacco-free prisons due to the high proportion of current smoking and
subsequent SHS exposure.
Chapter Five summarizes the dissertation results and discusses implications for
practice, policy change and future research. Findings from this study will be presented to
the KY DOC Commissioner and Medical Director and other correctional administrators.

Copyright © Alison R. Connell
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CHAPTER 2: SMOKE-FREE AND TOBACCO-FREE POLICIES IN AMERICAN
PRISONS
Introduction
Over the past 20 years there has been a worldwide trend by municipalities, states
and countries to enact smoke-free legislation. By April 2010, there were 19 states with
100% smoke-free laws in all workplaces, restaurants and bars and nearly 400 universities
with smoke-free policies according to the Americans for Nonsmokers' Rights (ANR,
2010). Correctional systems, including prisons and jails, increasingly are adopting
smoke-free policies and like many universities and hospitals are also going one step
further to becoming tobacco-free on the entire campus both inside and outdoors. With a
tobacco-free policy, no tobacco products are allowed on the campus, including smokeless
tobacco products such as chew or dip and spitless products such as snus.
The primary stimulus for smoke-free and tobacco-free policies is the harmful
health effects of tobacco use. Tobacco use and secondhand smoke (SHS) are the leading
causes of preventable death in the United States and the world. The World Health
Organization (WHO) states that tobacco causes five million deaths a year and that “one in
ten deaths worldwide” is attributable to tobacco (WHO, 2006). Smoking was calculated
to be the cause of 512 of every 2404 deaths, or 21% of deaths in the United States in
2000 (Peto, Lopez, Boreham, & Thun, 2006). For people who die between ages 35 and
69 years, 28% of the deaths are caused by smoking, with an average of 23 years of life
lost per death from smoking (Peto, et al., 2006).
Smoking and SHS cause heart disease (USDHHS, 2006). SHS causes 80% to
90% as much health damage as smoking (Barnoya & Glantz, 2005) and has been
estimated to be the cause of 46,000 deaths per year in the United States (CDC, 2006) and
58,400 acute myocardial infarctions (AMI) annually (Lightwood, et al., 2009). SHS is
defined as a combination of sidestream smoke (from the end of a lit cigarette, cigar or
pipe) and mainstream smoke (exhaled by the smoker) (ACS, 2010). Even brief exposure
to SHS from 15 minutes to 6 hours can increase the risk for cardiovascular disease by
increasing platelet activation (Burghuber, Punzengruber, Sinzinger, Haber, &
7

Silberbauer, 1986), impairing endothelial-dependent vasodilation (Otsuka, et al., 2001),
and lowering high density lipoprotein cholesterol levels (Moffatt, Chelland, Pecott, &
Stamford, 2004). SHS increases the risk of AMI by 25% to 31% (He, et al., 1999). The
overall relative risk for coronary heart disease for people who smoke is 1.78 and is 1.31
for people exposed to SHS (Barnoya & Glantz, 2005). However, there is a dosedependent effect from increasing cigarette exposure as seen in a large international study,
the INTERHEART study in 52 countries which was designed to examine cardiovascular
risk factors for AMI including the effects of smoking and secondhand smoke on the risk
for AMI (Teo, et al., 2006). The study enrolled 15,152 cases of first AMI matched by age
and sex with 14,820 controls in 52 countries. The odds ratio (OR) for AMI increased by
1.056 for every additional cigarette smoked per day so that a person who smoked 40
cigarettes per day had an OR of 9.16. There was an increased risk of AMI with increasing
hours of SHS exposure. The OR for having an AMI was 1.24 with 1 to 7 hours per week
of SHS which increased to 1.62 for people living with a spouse who smoked or with
those exposed to over 21 hours per week of SHS.
There are multiple respiratory effects from smoking and SHS. Cigarette smoking
is responsible for 89% of all lung cancer deaths and SHS is responsible for approximately
3000 lung cancer deaths yearly (Peto, et al., 2006). Cigarette smoking and SHS cause
airway obstruction through bronchoconstriction, inflammation and airway remodeling
(Flouris, Vardavas, Metsios, Tsatsakis, & Koutedakis, 2010). SHS of one hour duration
decreases lung function as evidenced by a reduction in forced expiratory volume in one
second (FEV1) (Flouris, et al., 2009).
Inmates have higher rates of current smoking than the non-incarcerated
population with rates ranging from 42 to 91 % with an average of 70-74% prevalence
which results in high secondhand smoke exposure for nonsmoking inmates and staff
(Cropsey, Eldridge, Weaver, Villalobos, & Stitzer, 2006; Durrah, 2005). A survey of 388
male inmates in a Kentucky state prison found that 71.4% were current smokers (defined
as smoking every day or some days) and 85.8% reported having smoked at least 100
cigarettes in their life (Connell, Winter, & Curd, 2007). This is similar to the 73.9% rate
of current smokers in a female Mississippi prison (Cropsey, Eldridge, & Ladner, 2004).
Kentucky and Mississippi may have higher proportions of inmates who smoke since there
8

is a greater prevalence of current smokers in those states (25.6% and 23.3% respectively)
(BRFSS, 2009; MMWR, 2009). This compares to a smoking prevalence of 20.6 %
among adults in the United States in 2008 and 2009 who are current smokers according
to the Centers for Disease Control and Prevention (CDC, 2010; MMWR, 2009). Even in
California which has a 14% prevalence of current smoking in the general population,
approximately 50% of inmates smoke (Gardiner, 2005).
This paper reviews the current literature on smoke-free and tobacco-free policies
in correctional systems, primarily at the state and federal levels. The first section explains
the difference between smoke-free and tobacco-free policies and the evolution of smokefree to tobacco free policies in correctional systems. The second section discusses the
health outcomes of smoke-free policies and potential health benefits in the incarcerated
population. The third section describes litigation surrounding the use of tobacco in
prisons and the unintended consequences of smoke-free and tobacco-free policies in
incarcerated populations. Finally, implications for research on outcomes of the tobaccofree policies in the prisons will be presented. A search of the current literature was
performed using the key words: smoke-free policy, tobacco-free policy, secondhand
smoke, prison, and inmates, in the Web of Science, PubMed, the Bureau of Justice
Statistics, and on state Departments of Corrections websites for specific laws and
policies.
The evolution of smoke-free and tobacco-free policies in correctional systems
Smoke-free laws or policies enacted by municipalities, states, and adopted by
correctional facilities typically require that there is no tobacco smoking indoors and also
within a certain distance of entrances, windows, and vents. There are increasing numbers
of municipalities that are also limiting outdoor smoking in public places such as cafes,
bus stops, sports arenas, parks and sidewalks (ANR, 2010). Institutions such as
universities, hospitals and prison systems are also adopting tobacco-free policies in which
no tobacco products are allowed on the facility’s campus such as the University of
Kentucky in November, 2009 (University of Kentucky Tobacco Policy, 2009).
Smoke-free policies vary among correctional systems in comprehensiveness of
the scope of the policy. Smoke-free policies in prisons usually mean that smoking is not
9

allowed indoors. Depending on the state, this may apply to inmates and staff or just
inmates. In some correctional systems, smoke-free means that there is no smoking
indoors but there are designated outdoor or covered outdoor smoking areas for staff
and/or inmates such as in the Federal Bureau of Prisons (FBOP) (FBOP, 2004). Indiana
implemented a smoke-free policy in 1997 in which no lit tobacco was allowed on the
grounds of the prison and cigarettes were no longer sold in the commissary (Cropsey &
Kristeller, 2003). The three primary reasons for adopting smoke-free policies cited by
State Departments of Corrections administrators are to reduce health care costs while
improving the health of employees and inmates, avoid litigation, and comply with
pending or current laws limiting smoking in state-owned facilities (Kauffman, et al.,
2008; Patrick & Marsh, 2001). However, indoor smoke-free policies in prisons where the
majority of inmates still smoke outdoors expose non-smokers to SHS. The 2006 U.S.
Surgeon General Report states that there is no risk-free level of SHS and that simply
separating smokers from nonsmokers does not protect them from the effects of SHS
(USDHHS, 2006).
Tobacco-free policies in prisons are stricter and disallow any form of tobacco on
the prison grounds. Under these policies tobacco is considered contraband similar to
illicit drugs such as heroin for staff and inmates. The exposure to SHS by non-smokers
and the health costs secondary to smoking by inmates and staff have been the primary
motivators for prisons to become tobacco-free. A warden in Kentucky expressed concern
that it was morally and fiscally irresponsible to sell cigarettes to pregnant women,
asthmatics or people with heart problems (Lamb, 2007). Providing health care to inmates
is federally mandated and is costly, which adds an extra stimulus to eliminate tobacco in
prisons to reduce morbidity and associated costs. Inmates are the only sub-population
group in the United States who are mandated to receive health care by the Supreme Court
which determined that refusing health care to inmates could be considered cruel and
unusual punishment ("Estelle v. Gamble," 1976). The cost of health care for all state
prisons in 2001 was $3.29 billion or 12% of prison operating costs (Stephan, 2004).
There has been a gradual transition in correctional systems from allowing smoke
in the entire prison, to indoor smoke-free policies followed by more comprehensive
smoke-free and tobacco-free policies which have become increasingly more prevalent in
10

recent years. Since the early 1990s, there has been an increase in the number of indoor
smoke-free policies in state and federal correctional systems. The American Correctional
Association (ACA) and the American Jail Association adopted resolutions in 1990
supporting non-smoking policies (Vaughn & del Carmen, 1993). The ACA reinforced
their support in 1999, 2004 and 2009 by ratifying the “Public Correctional Policy on
Nonsmoking Policies” which recommended non-smoking policies to improve the health
of staff and inmates, decrease medical expenses, and improve fire safety (ACA, 2009).
The National Commission on Correctional Health Care (NCCHC) Standard for Health
Services on the use of tobacco in prisons and jails recommends no smoking inside,
designated outside smoking areas, and availability of nicotine replacement products
(NCCHC, 2003).
In 1992, there were no prisons or prison systems that prohibited smoking entirely,
but six (12%) state correctional systems designated some cellblocks as non-smoking
(Vaughn & del Carmen, 1993). Twenty states’ administrators reported that the only
inmates who were provided with smoke-free cells were those with pre-existing medical
conditions that could be worsened by SHS exposure. Since there were only six states with
some smoke-free cellblocks, these inmates would still have been exposed to SHS from
neighboring cells. Five states reported that all inmates were provided a smoke-free
environment when it was requested. There were 16 states at that time in which no inmates
had smoke-free environments (Vaughn & del Carmen, 1993).
The number and strength of smoke-free policies in prisons has increased
gradually. A 1996 survey of all 50 states’ departments of corrections, the District of
Columbia and the Federal Bureau of Prisons reported that seven prison systems had
implemented smoke-free policies and 44 had limited indoor smoking in certain areas
(Patrick & Marsh, 2001). By 2002, 38 of 50 states had indoor smoking prohibitions or
limited indoor smoking (Zoroya, 2004). In 2004, the Federal Bureau of Prisons (FBOP)
prohibited lit tobacco products in all of its 105 prisons which house 180,000 inmates
(FBOP, 2004).
Smoke-free prison policies when limited to indoor areas do not reduce the rate of
current smoking, exposing non-smokers to SHS. With most indoor smoke-free policies
tobacco is still sold in the prison commissary and is used as currency between inmates
11

and sometimes creates a barter system between staff and inmates (Lankenau, 2001).
There are drawbacks to indoor-only smoke-free policies in prisons. One, the majority of
inmates can continue to smoke unless the entire prison is smoke-free. When the entire
prison is smoke-free and inmates are disciplined for visible smoking, there is more
incentive to smoke in the cells exposing others to SHS. There is also a risk of fire from
smoking paraphernalia which has led some state systems to also prohibit the use or sale
of matches in canteens.
Tobacco-free policies in prisons restrict any form of tobacco being brought into
the prison, sold in the canteen, or in vehicles on the grounds of the prison. Tobacco on the
premises is considered contraband for staff and inmates which in some states is a
misdemeanor and in others carries a felony penalty. This includes smokeless and spitless
tobacco, including snuff and snus. Some prison systems continue to allow nicotine
replacement therapy (NRT) products to be sold in the commissary and some do not.
California and South Carolina did not allow NRT because nicotine gum can be made into
a mold to make keys and disable locks (Gardiner, 2005; Polito, 2009) and nicotine
patches can be dried and smoked (Polito, 2009).
Correctional facilities in the District of Columbia became tobacco-free on August
1, 2004 (Corrections, 2004). California’s correctional systems became tobacco-free with
the passage of Assembly Bill 384 on July 1, 2005 which prohibits the use, sale and
possession of tobacco products by inmates and prison employees (Gardiner, 2005). By
2005, seven states had tobacco-free policies in their prisons (Colorado, Delaware, Idaho,
Indiana, Maine, Minnesota, and Nebraska) (Gardiner, 2005). A 2007 survey of the 50
states, the District of Columbia and the Federal Bureau of Prisons reported that 31 (60%)
had tobacco-free policies but most of these refer to indoor smoke-free policies as opposed
to completely tobacco-free prison policies (Kauffman, et al., 2008). By April 2010, nine
State Departments of Corrections’ prisons had tobacco-free prison policies and four more
are poised to become tobacco-free in 2010 including Nevada, Virginia, North Carolina,
and Georgia (Gardner, 2009; Mower, 2009; Sheinin, 2009). In some states, there is not
one policy that covers all prisons as in Kentucky where the overarching policy for all
prisons is smoke-free indoors with smoking allowed outside but five of the 16 state
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prisons also have tobacco-free campuses in which no tobacco is allowed on the prison
grounds (Adams, B. personal correspondence, March 12, 2009).
Health outcomes of smoke-free policies in the non-incarcerated population
The health benefits of smoke-free legislation affecting the non-incarcerated
population have been documented primarily in the reduction of cardiovascular and
respiratory diseases. The Institute of Medicine (IOM) concluded in 2009 that there was
sufficient evidence to infer a causal relationship between low levels of SHS and coronary
heart disease and that smoke-free policies reduce the risk for AMI (IOM, 2009). The
CDC recommends that people with heart disease avoid SHS (USDHHS, 2006). The
incidence of acute myocardial infarction (AMI) is the most commonly used policy
outcome measure. AMI as an outcome variable has the benefit of having distinct,
measurable diagnostic criteria as opposed to a respiratory outcome which is usually
measured by subjective reports of symptoms such as rhinorrhea, shortness of breath or
cough.
The impact of city, state and national smoke-free legislation on the reduction of
AMIs has been widely studied. The first report on AMI incidence was from Helena,
Montana after enactment of a smoke-free ordinance in 2002 which was followed by a
40% reduction in AMIs over the next six months compared to the same six months the
year before (Sargent, Shepard, & Glantz, 2004). A time-series analysis using the 18
month period before and after an ordinance was implemented in Pueblo, Colorado found
a 27% reduction in AMI hospitalizations in the City of Pueblo and no decrease in the
adjacent county where public smoking was allowed (Bartecchi, et al., 2006). New York
State passed a comprehensive smoke-free law in 2003. In the following year there were
3,813 fewer hospital admissions (8% reduction) for AMI than expected after adjusting for
seasonal and secular trends (Juster, et al., 2007).
Reductions in AMI have also been reported after entire countries enacted indoor
smoke-free laws. The hospitalization rate for AMIs in a region of Italy decreased by 11%
among people younger than age 60 after a prohibition on indoor smoking in public places
in 2005 (Barone-Adesi, Vizzini, Merletti, & Richiardi, 2006). There was a 17% reduction
in the risk for AMI in a meta-analysis of 11 studies from 10 locations worldwide where
13

smoke-free laws were enacted (Meyers, Neuberger, & He, 2009). A meta-analysis of
studies on AMI hospitalizations found a pooled risk estimate of 0.83 following smokefree policy enactment with the relative risk reduced to 0.64 after three years of follow-up
(Lightwood & Glantz, 2009).
In addition to improvements in cardiac health, the implementation of a smoke-free
ordinance was associated with reductions in emergency department visits for asthma and
respiratory symptoms. In Lexington, Kentucky in the 32 months after passage of a
smoke-free law prohibiting smoking in most indoor public places there was an overall
22% reduction of emergency department visits (p <.001; confidence interval (CI) 14% to
29%) compared to the 40 months prior to the law (Rayens, et al., 2008). Bar workers in
Perthshire, Scotland reported a decrease in respiratory symptoms within one month of a
smoke-free law (p < .001) (Menzies, et al., 2006). Fifteen of the 105 bar workers had
asthma. The FEV1 in the entire cohort increased by 8.2% after one month (CI 3.9-12.4, p
< .001) and by 15.7% in those with asthma (CI 5.7-25.7, p = .008).
In the non-incarcerated population where smoke-free policies do not restrict
individuals from smoking in private locations such as homes and cars, there have been
reductions in health care costs and in the proportion of current smokers. In New York
State after a comprehensive smoke-free law was passed in 2004, fewer hospital
admissions for AMI resulted in direct health care cost savings of $56 million (Juster, et
al., 2007). In the 20 months after the passage of a smoke-free ordinance in Lexington,
Kentucky there was a 32% decrease in current adult smokers, with no change in the
percent of smokers in comparable counties, resulting in an estimated $21 million in
healthcare cost savings per year (Hahn, et al., 2008).
After passage of smoke-free legislation there are lower levels of ambient SHS.
Particulate matter (PM2.5) which measures fine particle pollution such as SHS has a
National Ambient Air Quality Standard (NAAQS) for outdoor air for 24 hours of 35
micrograms per cubic meter (µg/m3) (EPA, 2009). PM2.5 was measured in eight
restaurants and a bowling alley before and after smoke-free legislation was passed with
levels decreasing by 79% one week after implementation of the law (Lee, Hahn, Riker,
Head, & Seithers, 2007). Comprehensive smoke-free laws result in greater decreases in
PM2.5 than partial smoke-free laws which encompass some but not all public venues.
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PM2.5 levels dropped by 88% from a mean of 161 µg/m3 to 20 µg/m3 in communities
with comprehensive smoke-free laws. However, levels varied dramatically based on the
type of venue in communities with a partial law: bars which were exempt had an average
of 235 µg/m3 in bars, while restaurants which were covered under the law had an average
of 10 µg/m3 (Lee, et al., 2009).
Potential health benefits of comprehensive smoke-free and tobacco-free policies in
prisons
Consistent with the high rates of smoking among inmates, the prevalence of
tobacco-associated disease burden is high. The leading cause of death in state prison
inmates is heart disease, accounting for 27% of the deaths in state prisons between 2001
and 2004 (Mumola, 2007). A study of the deaths in the Cook County Jail in Chicago, IL,
from 1994 to 2004 showed that heart disease was the number one cause of death with an
age-adjusted mortality rate of 312.1 per 100,000 per year compared to the national
average in the non-incarcerated population of 240.8 per 100,000 per year (Kim, et al.,
2007). Using data from a self-report survey of jail inmates in 2002 and of state and
federal inmates in 2004, the prevalence of hypertension was between 27.9% in jail
inmates and 29.5% in federal inmates, compared to the U.S prevalence of 25.6% (Wilper,
et al., 2009). The proportion of those with asthma was 7.7% for federal inmates and 9.8%
for state inmates compared to 7.5% for the U.S non-incarcerated population (Wilper, et
al., 2009). Cancer is the second leading cause of death in state prison inmates, with lung
cancer accounting for a third of the cancer deaths (Mumola, 2007).
The cost of treating chronic and acute diseases in inmates continues to climb each
year. In 2001 the cost for health care in the 50 state prison systems was $3.3 billion,
accounting for 12% of the total operating cost (Stephan, 2004). Kentucky Department of
Corrections reported that the highest medical cost by category was for the treatment of
diseases of the circulatory system which cost $3.4 million in the 10 months from July 1,
2008 to April 30, 2009 (Upton & Spaulding, 2009). Georgia spends $226 million per year
or 17% of its budget on health care (Sheinin, 2009). As the population ages it is
anticipated that health care costs will continue to climb. The cost of tobacco use in prison
inmates has not been estimated for all states or the federal prison system. In 1999, the
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California Department of Health Services estimated the cost of tobacco use among
inmates as $3,331 per smoker per year (TEROC, 2003).
Most States’ Departments of Corrections cite improvements in health and
reductions in health care costs as the primary motivators for implementing tobacco-free
policies; however there are no published data on the health outcomes or health care cost
savings of smoke-free or tobacco-free policies in prisons. Based on studies in the nonincarcerated population, reductions in the proportion of current smokers and cigarettes
consumed would be anticipated to provide health benefits with improvements in
cardiovascular and respiratory health. The Lightwood and Glantz (2009) study which
estimated a relative risk of 0.83 for having an AMI one year after smoke-free legislation
in public places was passed, assumed that only 23% of the population were current
smokers and that there was a relative reduction of cigarettes smoked by 29% using data
from a previous study showing that 3.8% of current smokers quit after a smoke-free
workplace law was enacted and the ones who continued to smoke smoked an average of
3.1 fewer cigarettes per day (Fichtenberg & Glantz, 2002). Given that inmates as a subpopulation group have excessively high rates of tobacco use with an average of 70%
current smokers, subsequent reductions in current smoking, tobacco use, and SHS
exposure following a tobacco-free policy would be expected to have greater
improvements in health than prisons with indoor smoke-free policies.
Reductions in current smoking and cigarette consumption have been reported in
prisons that have adopted comprehensive (indoors and outdoors) smoke-free policies and
tobacco-free policies (Cropsey & Kristeller, 2005b; Proescholdbell, et al., 2008). The
reductions vary by the comprehensiveness of the policy and by the security status of the
prison. After adoption of a comprehensive indoor and outdoor smoke-free policy in the
Indiana DOC where no cigarettes were sold in the canteen, 76% of current smokers
reported that they continued to smoke one month after the date of the policy
implementation (Cropsey & Kristeller, 2005a). Inmates were surveyed in two prisons,
one of which had a tobacco-free policy and one with a tobacco-free indoor policy, and
reported a higher prevalence of current smoking in the prison with the partial policy
(64%) than inmates in the prison with a complete tobacco-free policy (42%). In a
qualitative survey of 140 inmates and 50 staff from 10 jails and six prisons in eight states,
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inmates reported that in prisons with a lower security status (i.e. minimum security or
work release), there was greater ease of violating a tobacco-free policy than in higher
security prisons. Maximum security prisons had the least tobacco smuggled into the
prison (Lankenau, 2001).
Litigation related to tobacco use in prisons
Litigation has been a driving force in prompting smoke-free policies in the
corrections environment. The most prominent court case that went to the U.S. Supreme
Court was in 1993 when a non-smoking inmate charged that his cell-mate smoked five
packs a day, causing the plaintiff’s current and future health problems ("Helling v
Mckinney," 1993). The Court upheld the plaintiff’s claim of health damage from SHS,
citing the Eighth Amendment which bars criminals from infliction of cruel and unusual
punishment. The court ruling referred to the case of Estelle v. Gamble ("Estelle v.
Gamble," 1976) which stated “that deliberate indifference to serious medical needs of
prisoners” constitutes an Eighth Amendment violation (p.103). This judicial ruling set
the precedent for inmates to receive a standard of medical care, the denial of which would
“result in pain and suffering which no one suggests would serve any penological
purpose” (p. 103). A lawsuit in Wisconsin by an inmate with severe chronic asthma
claimed that the warden and other prison staff acted with deliberate indifference in
allowing prisoners to smoke in violation of prison policy (Sweda, 2004). The Court of
Appeals upheld his case stating that his health was being endangered by SHS exposure.
An asthmatic inmate was awarded $54,750 in compensatory and punitive damages
because he had been denied a smoke-free cell for five years ("Reilly v. Grayson," 2001).
However, in lower courts, the standard of Helling v. McKinney has not always
been maintained (Wilcox, 2007a). In Michigan in 2003, the court ruled that the potential
health hazards from SHS did not represent a sufficiently serious medical risk and there
was not deliberate indifference because the prison had adopted an indoor non-smoking
policy ("Henderson v. Martin," 2003). The Eleventh Circuit ruled against an inmate’s
claim that SHS exposure was harmful citing lack of evidence of unreasonable high SHS
levels ("Kelley v. Hicks," 2005).
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Litigation opposing smoke-free policies has also been brought against state
departments of corrections. In 1997, eight lawsuits were dismissed by the Massachusetts
Superior Court which alleged that smoke-free policies violated inmates’ Eighth
Amendment rights and “amounted to intentional infliction of emotional distress” (Young,
2002). The smoke-free policy that was being contested was originally implemented as a
result of a class-action lawsuit from non-smoking inmates who were concerned about
SHS exposure.
In some Western states, American Indians have been allowed to use tobacco in
religious ceremonies. However, in South Dakota this policy was reversed by the Director
of Prison Operations because tobacco was too addictive to be used for ceremonies and
was being abused and traded (Hult, 2009). This is currently being challenged by the
Native American Council of Tribes.
Unintended consequences of tobacco-free policies in correctional systems
While there are potential benefits of tobacco-free policies in prisons there may
also be unintended consequences which impede the transition to tobacco-free prison
systems including: decreased revenue from tobacco sales, enforcement issues, tobacco as
contraband, and concerns about inmate tension and behavior disruption. The State of
California reported that in 2003 tobacco sales by inmates generated $1 million in tobacco
taxes and $370,000 in sales tax which was lost after the state prisons became tobacco-free
(Gardiner, 2005). This report suggested that there would be an estimated $280 million in
savings in health care costs but this was derived by calculating the approximate health
care costs from tobacco use per inmate times the estimated number of current smokers
and subtracting that amount from the state healthcare budget. This is not an accurate
estimation since inmates may have permanent health damage from tobacco use and the
effects of quitting are not immediate.
Enforcement of smoke-free and tobacco-free policies in prisons varies by prison
staff and among and within prisons. The biggest problem with enforcement is that
tobacco is the primary black market currency in prisons and becomes more valuable with
increased restrictions on its use (Lankenau, 2001). Inmates earn an average of 0.50¢ to $1
a day which is deposited in the prison accounts and used to buy food, snacks, hygiene
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products and cigarettes if available at the prison canteen. Since money is not available for
currency and the majority of inmates are current smokers, loose tobacco and rolled
cigarettes are the currency for buying services, goods, and favors. Lankenau (2001)
surveyed 140 inmates and 50 staff and officers in 2000 about tobacco use in prisons with
smoke-free and tobacco-free policies and reported that inmates have elaborate
mechanisms for getting tobacco into the prisons, selling it and smoking it. A “mule” who
smuggles the tobacco into the facility may be an officer, another inmate on community
work-duty or a community service worker. The officers who participate in the tobacco
black market can charge between $20 and $50 per pack of cigarettes and could earn an
entire week’s pay from one tobacco or cigarette transaction. The inmate then sells the
cigarettes for $200 to $500 per carton..
Once prisons become tobacco-free as opposed to being smoke-free or having an
indoor smoke-free policy, tobacco becomes an even higher prized commodity which has
been reported to overtake heroin as the number one smuggled contraband item (NCCHC,
2004). The Maryland DOC reported that tobacco has become the leading smuggled item
and that a can of loose tobacco can sell for $1,000 (Garland, 2005). In Ohio, a year after
the prisons became tobacco-free, a can of loose tobacco sold for $300 and a cigarette for
$10 (Johnson, 2010). In response to this trend, some states (i.e., New York and Texas)
consider smuggling tobacco into prisons a felony (Byrne, 2006). Once prisons become
tobacco-free, chips, candy or other items from the commissary may become currency as a
substitute for tobacco (Sheinin, 2009).
Enforcement may be hampered by the security status of the prison or by the
comprehensiveness of the policy. Minimum security prisons are relatively loosely
guarded allowing inmates to have more opportunities for contact with the nonincarcerated population. Many medium security prisons have a minimum security
dormitory outside the fenced area for low-risk inmates who do maintenance or work in
the community on road crews. The more access the inmate has to the outside, the easier it
is to smuggle tobacco in to the prison (Lankenau, 2001). Indoor smoke-free policies are
hard to enforce because inmates may smoke in their cells at night and unless the smoking
is seen, it cannot be cited. Prisons that have indoor and outdoor smoke-free policies are
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also hard to enforce because there are many ways of hiding the tobacco, the smoke, and
the lighting paraphernalia.
Variations in the enforcement of smoke-free and tobacco-free policies were found
in a study of air quality at four prisons in Kentucky (Unpublished, McGuire, & Connell,
2010). Four prisons were chosen as study sites: two of which had indoor smoke-free
policies (outdoor smoke allowed) and two of which had tobacco-free policies (no tobacco
on campus). Fine particulate matter (PM2.5) was measured for two hours in two
dormitories at each prison (see Table 2.1). At the two prisons with smoke-free policies in
two medium security dormitories, the maximum PM2.5 over the two hour period was 37.1
and 37.5µg/m3, while the minimum security dormitories in those prisons had PM2.5 of
17.4 and 16.5 µg/m3. At the two prisons with tobacco-free policies there were variations
in PM2.5between dormitories. At one tobacco-free prison the maximum PM2.5 was 15.0
µg/m3 in a medium security dormitory compared to 4.1 µg/m3 in the minimum security
dormitory. At the other tobacco-free prison, which was entirely minimum security, one
dormitory had a maximum PM2.5 of 30.4 µg/m3 while another dormitory in the same
prison had a maximum PM2.5 of 11.2 µg/m3 showing a possible difference in enforcement
of the policy even within one prison with the same security status (see Table 2.1).
Enforcement may not be the only reason for the difference in PM2.5 levels. Inmates in a
minimum security dormitory may not want to risk a disciplinary violation which might
result in loss of privileges, time for good behavior or having to go back into the medium
security area “behind the fence” rather than the relative freedom of minimum security. A
study in North Carolina reported that there was a 98% decrease in PM2.5 from 305 µg/m3
before to 6.5µg/m3 in a dormitory after a comprehensive tobacco-free policy was
implemented (Proescholdbell, et al., 2008).
Another unintended consequence of tobacco-free policies in prisons is the
incidence of behavior disturbances among inmates. In Georgia at the Lee Correctional
Institution in Leesburg there were about 150 inmates who refused to work after an indoor
smoke-free policy was implemented (Sheinin, 2009). However, the NCCHC and the
National Network on Tobacco Prevention and Poverty surveyed 100 prison and jail
administrators and juvenile detention facilities in 2000 (NCCHC, 2004) and reported few
incidents of behavior problems in prisons that adopt smoke-free or tobacco-free policies.
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Policy analysis implications
The results of policy analysis studies following passage of smoke-free laws in the
non-incarcerated world may not be generalized to prison settings. Prisons have some
similarities with the non-incarcerated population but have much dissimilarity. In the nonincarcerated population when there is an indoor smoke-free law, an individual has the
ability and the right to smoke in his or her car, house, or land but may not in indoor
public places or workplaces. In a prison with a comprehensive smoke-free policy or in a
tobacco-free prison, the inmate loses the right to smoke and the only option is to partake
in illicit activity to smoke. This may result in a greater decrease in current smoking rates
than the non-incarcerated population. There are also varying strengths of smoke-free
policies and variations in enforcement of either smoke-free or tobacco-free policies
among and within prisons, which create challenges in determining the effect of these
policies on health outcomes.
The health benefits of smoke-free policies have been studied in communities,
states, and countries and significant benefits in cardiovascular and respiratory health have
been documented. However, there are unique challenges that are specific to the
corrections community that impact the health outcomes of tobacco policies. One of the
primary challenges in studying the health outcomes of policy initiatives in prisons is the
transient nature of the inmate population, with as many inmates discharged each year as
are committed. For example, in 2008 the Kentucky Department of Corrections admitted
14,426 offenders and released 15,642 offenders but had an average population of 21,700
at any given point in time (Adams, B., personal communication, March 23, 2009).
Inmates move fairly frequently between prisons or jails and some of the prisons may be
tobacco-free while others have indoor smoke-free policies where outdoor smoking is
allowed. Thus, the exposure to the policy by individual inmates becomes hard to
quantify.
The long-term effect of a tobacco-free policy is difficult to measure. The majority
of inmates who are housed in a tobacco-free environment return to smoking once moved
to an environment that allows smoking or when discharged, and the health benefits from
tobacco-free policies may not be sustained (Cropsey & Kristeller, 2005a). When inmates
are discharged they are usually lost to follow-up precluding long-term follow-up.
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Research that examines the effect of a tobacco-free policy on immediate or shortterm health outcomes such as respiratory symptoms or physiologic measures like FEV1
may be able to minimize the attrition of a long-term study. In prisons that are becoming
tobacco-free, a pre-post-design could be conducted which measures salivary cotinine
levels before and after implementation. Surveying inmates on their personal use of
tobacco in a tobacco-free prison is hindered by the disciplinary consequences associated
with violating prison policy.
Cost as an outcome measure of the effect of tobacco-free policies in prisons is
difficult to track in prisons. Health care costs continue to rise and the inmate population is
aging which increases health care costs. However, costs may stabilize or decrease as the
prison population shrinks due to changes in sentencing laws and parole rules designed to
reduce the prison population. The prison population increased by 0.8% in 2008 which is
the slowest rate since 2000 so the costs may stabilize based on these changes and not on
the tobacco policy (Sabol, et al., 2009).
Conclusions
The general movement toward smoke-free legislation is a relatively recent trend
in local communities, states and countries. Correctional systems are also adopting
policies that vary in scope from restricting smoking indoors, to complete smoking
prohibition indoors and out, to tobacco-free prisons in which all tobacco products are
considered contraband for staff and inmates. This trend has been prompted by the need to
reduce health care costs, morbidity, and mortality among inmates and staff. It also may
be secondary to litigation by inmates who are increasingly concerned about exposure to
SHS. National and international research continues to show the benefits of reducing SHS
exposure, and the widely accepted knowledge that there is no safe level of SHS
(USDHHS, 2006). Improving the health of inmates is an important public health issue
since there are currently 7.3 million people in the United States who are under some form
of correctional supervision including probation, parole, jails, state and federal prisons
(Glaze & Bonzcar, 2009).
Studies in prisons mirror the results from community-based studies in that the
strength and enforcement of the tobacco-related policy determine the reduction in SHS
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and current smoking. Indoor smoke-free policies do not reduce current smoking
prevalence which in inmates is, on average, more than three times the proportion of
current smokers in the United States (Connell, et al., 2007). Variations in enforcement of
indoor smoke-free policies may result in high indoor SHS. Comprehensive smoke-free
prison policies and tobacco-free policies have been associated with reductions in cigarette
consumption. However, even in prisons that have adopted complete smoke-free and
tobacco-free policies, tobacco is smuggled in to the prison and many inmates continue to
smoke especially in prisons with low security status.
Comprehensive smoke-free (indoors and out) and tobacco-free policies in prisons
may result in improvements in the health of inmates and correctional staff including
lower rates of coronary heart disease, AMIs, and asthma exacerbations. Subsequent
reductions in health care costs have been reported in the non-incarcerated population
following enactment of smoke-free legislation. Research on health outcomes after prisons
adopt smoke-free or tobacco-free policies has not been reported in the literature.
There are unintended consequences of tobacco-free policies in the correctional
system such as reduced canteen sales and varied enforcement levels within and among
correctional officers and prisons. Tobacco may become a primary contraband item to be
smuggled into the prison which in some cases is a misdemeanor but in Texas has been
reclassified as a felony due to the number of employees smuggling tobacco (Wilcox,
2007b). Concerns about inmate tension following a tobacco-free policy have occurred but
are minimal.
In spite of continued illicit smoking by some inmates and variations in
enforcement, it is anticipated that tobacco-free policies will produce declines in AMI
incidence and improvements in lung function and decrease health care costs primarily
due to the health benefits from reductions in cigarette consumption and SHS exposure.
Reducing health risks by implementing and enforcing a tobacco-free prison policy during
incarceration for the revolving population of approximately 1.64 million people in state
and federal prisons may improve the health of a portion of the population that has high
risk factors for cardiovascular and respiratory diseases. If improvements in health and
reductions in health care costs are goals for correctional policy makers and
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administrators, comprehensive tobacco-free policies with strict enforcement are more
likely to achieve that goal.

Copyright © Alison R. Connell

24

Table 2.1 Measurements of particulate matter (PM2.5) in prisons with indoor smoke-free
and tobacco-free policies (N = 4)
Security status
of dormitory

Highest level of
PM2.5 µg/m3

Security status
of dormitory

Highest level of
PM2.5 µg/m3

EKCC (Indoor
smoke-free)

Medium

37.1

Minimum

17.4

LSCC (Indoor
smoke-free)

Medium

37.5

Minimum

16.5

BCC
(Tobacco-free)

Medium

15.0

Minimum

4.1

KCIW
(Tobacco-free)

Minimum

30.4

Minimum

11.2

(McGuire and Connell, unpublished, 2010)
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CHAPTER 3: TOBACCO-FREE PRISON POLICIES AND RESPIRATORY HEALTH
AMONG INMATES
Synopsis
Purpose: The purpose of this study was to evaluate the effect of a tobacco-free
prison policy compared to an indoor smoke-free policy on the respiratory health of
inmates who have asthma and/or COPD.
Hypothesis: It was hypothesized that due to reductions in the rate of current
smoking and subsequent SHS in tobacco-free prisons, inmates in these prisons would use
fewer medications for asthma and/or COPD compared to inmates with asthma and/or
COPD in prisons that were not completely tobacco-free.
Method: This study was a multivariate time series analysis to evaluate the effect
of tobacco-free policies in two state prisons on the respiratory health of inmates with
asthma and/or COPD compared to inmates with asthma/COPD who were incarcerated at
two state prisons designated as smoke-free (smoke-free indoors, with smoking allowed
outdoors). Medications for asthma and/or COPD including oral medications and inhalers
were used as proxy markers for respiratory health.
Results: There was an immediate effect of the tobacco-free policy on the use of
short-term inhalers such as albuterol and ipratropium within a month after the policy was
implemented. However, the rate of use gradually increased to the level prior to the policy
implementation within 12 to 15 months at the tobacco-free prisons. The rate of refills of
long-acting inhalers had opposite trends before and after implementation of the tobaccofree policy. There was no effect of the policy intervention on the use of oral medications
but there may have been a prescribing effect by the primary care providers with
differences in the use of certain medications in the four prisons.
Conclusion: Although there was an immediate reduction in short-acting inhaler
use the effect was not sustained which may be reflective of the rapid turnover in the two
tobacco-free prisons or the minimum security status which may facilitate tobacco use by
inmates due to fewer physical restrictions in the prison setting.
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TOBACCO-FREE PRISON POLICIES AND RESPIRATORY HEALTH AMONG
INMATES
Introduction
Cigarette smoking is the leading cause of preventable death in the world, killing
50% of smokers, according to the World Health Organization (WHO) (WHO, 2006).
Almost all lung cancer deaths (89%) and 34% of all cancer deaths are attributed to
smoking (Peto, et al., 2006). Smoking related damage to the respiratory system results in
increased risks for chronic obstructive pulmonary disease (COPD), chronic bronchitis,
asthma and upper airway infections (Trupin, et al., 2003). Secondhand smoke (SHS)
causes 80% to 90% as much health damage as smoking (Barnoya & Glantz, 2005) and
has been estimated to be the cause of approximately 3400 lung cancer deaths per year
(Peto, et al., 2006). The 2006 U.S. Surgeon General’s report reviewed the scientific
evidence to date and concluded that there is no risk-free level of exposure to SHS and
that separate smoking areas within a building cannot eliminate SHS. Secondhand smoke
is defined by the American Cancer Society (ACS) as a combination of sidestream smoke
which is the smoke from the end of a lighted cigarette, cigar or pipe, and mainstream
smoke which is the smoke exhaled by the smoker (ACS, 2010).
Prison inmates have a higher prevalence of current smoking than the nonincarcerated population with rates from 42 to 91 percent (average of 70-74%) (Connell, et
al., 2007; Cropsey, et al., 2006; Durrah, 2005) compared to 20.6 percent in the U.S.
(CDC, 2010; MMWR, 2009). The Centers for Disease Control and Prevention (CDC)
defines a current smoker as having smoked at least 100 cigarettes in one’s life and
smoking every day or some days in the past 30 days.
Consistent with the high rates of smoking among inmates, the prevalence of
tobacco-associated respiratory disease burden is high. Cancer is the second leading cause
of death in state prison inmates with lung cancer accounting for a third of the cancer
deaths, similar to the U.S. non-incarcerated population (Mumola, 2007). The proportion
of people with asthma was 7.7% for federal inmates and 9.8% for state inmates compared
to 7.5% for the U.S non-incarcerated population (Wilper, et al., 2009). It is important to
note that these estimates are based on self-report which are not always reliable.
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Cigarette smoking and SHS cause airway obstruction through bronchoconstriction, inflammation and airway remodeling (Flouris, et al., 2010). SHS of one hour
duration decreased lung function as evidenced by a 20 to 25% reduction in forced
expiratory volume in one second (FEV1) (p = < .05) (Flouris, et al., 2009). Non-smoking
hospitality workers (n =88) in Vancouver who were employed in bars and restaurants
where smoking was allowed had increased odds ratios (OR) for cough (OR 3.5), phlegm
production (OR 8.5) and wheeze (OR 3.8) (Dimich-Ward, Lawson, Hingston, & ChanYeung, 2005). Workplace SHS increased the odds for cough and phlegm by 65% in
workers in Hong Kong who had never smoked and had no SHS at home (Ho, Lam,
Chung, & Lam, 2007). The risk of a new-onset of asthma in a random sample of neversmoking adults aged 18 to 60 increased by 39% with SHS exposure (Leuenberger, et al.,
1994). In a survey of 377 people with COPD only 19% had never smoked with a
population-attributable risk of 51% for current or former smoking, after controlling for
demographics and self-reported occupational exposure to other irritants (Trupin, et al.,
2003).
Cigarettes contain over 600 ingredients which when burned create more than
4000 chemicals including acetone, ammonia, benzene, butane, carbon monoxide,
hydrogen cyanide, lead, nicotine, sulfur dioxide tar, and toluene (USDHHS, 2006).
Tobacco smoke also contains at least 50 known carcinogens. SHS contains levels of
endotoxins that increase inflammation that are 120 times higher in SHS than in nonexposed air (Larsson, Szponar, & Pehrson, 2004).
Two other less conspicuous but potentially damaging forms of tobacco smoke
exposure are thirdhand smoke and outdoor tobacco smoke. Thirdhand smoke is the gas
and particle residue from tobacco smoke that lingers in the air and on surfaces after the
cigarette is extinguished (Winickoff, et al., 2009). The nicotine residual on indoor
surfaces such as floors, walls, furniture and clothing reacts with nitric oxide to form
tobacco-specific nitrosamines (TSNA) which are carcinogenic. These TSNAs can enter
the body through inhalation of contaminated dust (Sleiman, et al., 2010).
As indoor smoke-free legislation is enacted, outdoor tobacco exposure still occurs
and can result in high levels of nicotine among non-smokers. In a study of 10 nonsmokers who spent an average of 25 days at outdoor bars and restaurants that allowed
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smoking in Athens, Georgia, salivary cotinine increased by up to 162% from baseline
after outdoor SHS exposure (Hall, et al., 2009). Outside nightclubs, the average level of
particulate matter (PM2.5) was 32.2µg/m3 , close to the National Ambient Air Quality
Standard (NAAQS) for 24 hours (35 µg/m3) (EPA, 2009).
Smoke-free policies in cities and countries have been shown to decrease ambient
levels of cigarette-related chemicals. In Dublin before a smoke-free ordinance was passed
the levels of benzene and 1,3-butadiene in two pubs averaged 4.83 µg/m3 and 4.15 µg/m3
respectively. These levels dropped to 0.54 µg /m3 and 0.22 µg /m3 after successful
implementation of the policy which had a 97% compliance nationwide (McNabola,
Broderick, Johnston, & Gill, 2006). Nine hospitality venues in Georgetown, Kentucky
had PM2.5 levels averaging 84µg/m3 before an indoor smoke-free workplace law was
enacted which decreased to 18µg/m3 one week after the law went into effect (Lee, et al.,
2007). In nonsmokers, cotinine levels, a metabolite of nicotine, decreased by 89% from
baseline one year after Scotland enacted smoke-free legislation in March, 2006 (Semple,
et al., 2007).
The decreases in environmental irritants, nicotine and fine particle air pollution
after smoke-free laws have been enacted are associated with improvements in respiratory
symptoms. In Lexington, Kentucky there was an overall 22% reduction of emergency
department visits for asthma in the 32 months after passage of a smoke-free law
prohibiting smoking in most indoor public places compared to the 40 months prior to the
law (p <.001; confidence interval (CI) 14% to 29%) (Rayens, et al., 2008). Hair nicotine
levels declined significantly in bar workers (t = 2.3, p = .03) in Lexington, KY and they
also reported significant reductions in wheezing, irritated eyes and mucus production
after passage of the smoke-free ordinance in public places (p values from .02 to .05)
(Hahn, et al., 2006). Bar workers in Perthshire, Scotland reported a decrease in
respiratory symptoms within one month of a smoke-free law (p < .001) (Menzies, et al.,
2006). Fifteen of the 105 bar workers had asthma. The FEV1 in the entire cohort
increased by 8.2% after one month (CI 3.9-12.4, p < .001) and by 15.7% in those with
asthma (CI 5.7-25.7, p = .008).
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Tobacco policies in prisons
There are three basic types of tobacco policies in prisons: indoor smoke-free with
smoking allowed outdoors or in designated areas; comprehensive smoke-free policies
which prohibit all smoking on the grounds; and tobacco-free policies in which all tobacco
products are prohibited on the prison grounds. Tobacco-free policies include smokeless
and spitless tobacco and may also apply to nicotine replacement products. Typically these
policies apply to all staff, inmates, and visitors.
Within one state system the policies may vary. The Kentucky Department of
Corrections (KYDOC) has had a smoke-free policy for over ten years in its 13 state
prisons. The KY General Assembly reinforced this policy with the passage of KY House
Bill 55 in 2006 which required most state offices and common areas to be smoke-free
including all correctional facilities except the Kentucky State Penitentiary at Eddyville
which is the maximum security prison for male state inmates (2006). Five of the KY
DOC prisons have also adopted a tobacco-free campus policy in which no tobacco of any
form is allowed beyond the security gate at the front entrance. This policy applies to
inmates, visitors, and staff and in prison vehicles. Any tobacco found on the premises is
considered contraband similar to illicit drugs such as heroin, and the person (staff or
inmate) in possession of tobacco products is subject to disciplinary procedures.
Air quality studies in prisons have shown that there can be significant reductions
in SHS following tobacco-free policies but enforcement is the critical factor in reducing
tobacco use. In North Carolina there was a 98% decrease in SHS as measured by PM2.5 in
a dormitory where the level was 305 µg/m3 before a tobacco-free policy and 6.5µg/m3
after the policy was implemented (Proescholdbell, et al., 2008). However, levels of SHS
may vary even within prisons. In three Kentucky prisons, two of which had an indoor
smoke-free policy and one that had a tobacco-free policy, the maximum level of PM2.5 in
three medium security dormitories was more than double that of the maximum level of
PM2.5 in minimum security dormitories in the same prisons (McGuire & Connell, 2010).
Research on the effects of tobacco-free policies on the health of inmates has not
been published. Given that there have been improvements in lung function and
respiratory symptoms after passage of smoke-free laws in communities and countries it is
anticipated that a tobacco-free policy in prisons which prohibits all tobacco products on
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the grounds would result in improvements in the respiratory health of inmates. The
purpose of this study was to evaluate the effect of a tobacco-free prison policy compared
to an indoor smoke-free policy on the respiratory health of inmates who have asthma
and/or COPD. It was hypothesized that due to expected reductions in the rate of current
smoking and subsequent SHS in tobacco-free prisons, inmates in these prisons would use
fewer medications for asthma and/or COPD compared to inmates with asthma and/or
COPD in prisons that were not completely tobacco-free.
Methods
This study was a multivariate time series analysis to evaluate the effect of
tobacco-free policies in two state prisons on the respiratory health of inmates with asthma
and/or COPD compared to inmates with asthma/COPD who were incarcerated at two
state prisons designated as smoke-free (smoke-free indoors, with smoking allowed
outdoors). Medications for asthma and/or COPD including oral medications and inhalers
were used as proxy markers for respiratory health. The study period was at least 12
months prior to and 18 months after the implementation dates of the respective policy.
Institutional Review Board approval was obtained through the University of Kentucky
and in addition, was approved by the Commissioner for the Kentucky Department of
Corrections.
Study Setting
Four Kentucky state prisons were chosen for this study, two of which adopted
tobacco-free campus policies and two that had indoor smoke-free policies. Blackburn
Correctional Complex (BCC) and Kentucky Correctional Institution for Women (KCIW)
implemented tobacco-free policies between July and September, 2007. The tobacco-free
policy applies to all tobacco products and to all staff, inmates and visitors. The two
prisons with smoke-free policies (smoke-free indoors, with smoking allowed outdoors)
were Eastern Kentucky Correctional Complex (EKCC) and Little Sandy Correctional
Complex (LSCC). Table 3.1 describes the population and the security level of inmates at
each prison.
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The study prisons could not be matched by security status or gender because
security status varied between the two policy study groups and there is only one female
prison managed by the KYDOC. BCC is the largest minimum security prison in the KY
DOC with the other minimum security prisons having a population of 300 inmates or
fewer; matching a minimum security prison of the same size was not possible. Matching
prisons based on gender was also not possible since the only other female prison in
Kentucky is managed by a private company and comparable data were not available. The
majority of the inmates in the two smoke-free prisons (EKCC and LSCC) were in
medium security and they live and work “behind the fence” with no access to the free
world (see Table 3.1). Inmates living in a minimum security prison such as in BCC
usually have fewer restrictions and often work on community needs projects such as
road-cleaning crews, and consequently, have more access to the outside world and more
opportunity to use tobacco when off the prison campus.
Diamond Pharmaceutical is the vendor for the 13 KY DOC prisons. Prescriptions
are electronically ordered by the primary care providers (PCP) at the prisons via the
electronic health record (EHR). Once the order is approved by a Diamond pharmacist,
maintenance medications are distributed in 30-day blister packs. Some inmates receive
medication while being directly observed by medical staff personnel and a corrections
officer (Direct Observation Therapy or DOT) while other inmates are permitted to
receive a thirty-day supply of medications for self-administration (Self-administered
Medications or SAMs). The SAMs inmate population functions similarly to most nonincarcerated patients: they fill or refill medication every month and are responsible for
taking their medication without supervision. To refill medications, inmates on SAMs
must come to “pill call” which is at a designated time in each prison to request a refill of
their medication and then return 2-3 days later to pick up the next month’s supply of
medication (similar to the non-incarcerated population). Inmates who get their
medication by the DOT method must present to “pill call” daily to take their medication
directly from medical staff who document acceptance or refusal to take the medication.
Refills for DOT medications are requested by prison staff when there is one week’s
supply of pills left in the blister pack. Very few respiratory medications are administered
using the DOT method since most are inhalers and many are used as needed.
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Study Sample
The unit of analysis in the study was the number and types of medications for
asthma and/or COPD (N = 6,374) that were sent by Diamond Pharmaceutical to the
prison each month. These medications were dispensed to 1,109 inmates over the course
of the study (see Table 3.4). However, since these data were obtained from the pharmacy
vendor only demographic data including inmate number, date of birth, gender and prison
were available. Tracking individual inmates’ movement between and among prisons was
not feasible which precluded a count of medications per treated patient per month since it
was unknown on a monthly basis if the inmate continued to be housed in each prison.
Inmates typically move multiple times each year between prisons and also shorter trips to
court appearances, medical consultations or hospitalizations. Typically inmates move
from one prison to another an average of 1.1 times per year and have been reported to
move up to seven times in one year (Unpublished, Connell, 2010). With over 1,100
inmates over three years, tracking these data longitudinally was not feasible.
Measures
Medications were in the form of either inhalers or pills. There are two basic types
of inhalers for asthma/COPC: rescue inhalers which are used as needed for immediate,
short-term bronchodilation and long-term inhalers which are taken daily to reduce airway
inflammation and chronic bronchoconstriction. Albuterol, ipratropium bromide and
Combivent (albuterol and ipratropium) metered dose inhalers (MDI) were coded as shortacting. Q-var, Advair, Azmacort, and Spiriva were coded as long-acting inhalers. All oral
medications were coded as oral (see Table 3.2).
Data from Diamond included the inmate number, birth date, medication, quantity
and date the medication was sent to the prison. This date was not necessarily when the
inmate picked it up from “pill call” but it is an indicator that the inmate or the DOC staff
requested a refill on the medication. The numbers of prescriptions ordered by the PCP for
the medication for these drugs were not analyzed because that would not reflect actual
use of the medication by the inmate.
The tobacco-free policy was termed “intervention” and was entered as a binary
variable of ‘0’ for smoke-free (indoors) at EKCC and LSCC for each month in the entire
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study period and 15 months at BCC and 12 months at KCIW prior to the tobacco-free
policy. The policy variable was coded as ‘1’ for tobacco-free for the 18 months after
implementation of the tobacco-free policy at BCC and KCIW.
In order to calculate the medication rates as metered dose inhalers (MDI) per
1000 inmates, monthly counts of all the inmates in each prison were obtained from the
Kentucky Offender Management System (KOMS), the database that tracks all inmate
locations and movement. This allowed for equal comparisons among facilities of
different sizes. Age was entered as the age when the refill was sent. Smoking history of
the sample was not available since the data were derived from the pharmaceutical vendor.
Study Period
The full 36-month period was not available for all four study prisons because
Diamond began the contract with the KYDOC on July 1, 2006 (see Table 3.3). For the
two tobacco-free prisons (BCC and KCIW), data were available for 18 months after
policy implementation, but the pre-policy periods varied. Data were available for 15
months pre-policy at BCC and 12 months pre-policy at KCIW so that the total study
period was 33 months at BCC and 30 months at KCIW. For the two prisons with a
smoke-free policy (smoke-free indoors, outdoor smoking allowed), data were available
for 30 months at EKCC and 18 months at LSCC. The data from Diamond were not
available for LSCC prior to July 2007 because the facility had been privately managed by
a different pharmacy vendor.
Statistical Analysis
Descriptive statistics were used to summarize the sample of inmates who were
taking the asthma/COPD medications including demographic data of gender and age
(range and means) in each prison. Race/ethnicity data were not available in the Diamond
database.
Poisson regression with a fixed effect for the facility was used in a generalized
linear mixed model. The Poisson regression was the most appropriate technique given the
small number of inhalers each month since it assumes a non-parametric distribution and
determines the rate of medication use from the logarithm of the offset variable. The
monthly inmate count in each prison from KOMS data was entered as the offset variable.
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Facility was included in the model as a fixed effect and an intervention indicator variable
was entered as a binary categorical variable for the smoke-free or tobacco-free policy.
”Month time” was entered as the number of the month in which a particular data point
was collected during the course of the study, starting with July 2006 as ‘1’ until the end
of data collection which was from 1 to 30 for KCIW and EKCC, 1 to 33 for BCC, and
from 13 to 30 for LSCC since the data collection started in July 2007. Seasonality was
found not to be significant when a 12-month lag autoregressive term was entered in an
autoregressive integrated moving-average (ARIMA) model. Two-way interaction terms
were included: month time*facility, intervention*month time, intervention*facility, and a
three-way interaction of intervention*month time*facility.
Results
From July 2006 through December 2009, there were a total of 6,374 inhalers and
oral medications for asthma and/or COPD dispensed to a total of 1,109 inmates (see
Table 3.4). There were differences in the number of inmates among the prisons over the
three-year study period (F = 25.22, df = 3, p < .001). KCIW (all female) had almost twice
the number of inmates than the male facilities which is likely due to shorter sentencing
times and higher turnover of inmates. BCC also had a higher proportion of treated
patients for its size suggesting high turnover rates. Among the four different prisons, the
mean age at the time the inmate refilled the medication was significantly different with
KCIW having the lowest mean age (39.2 years), and BCC having the highest ( 45.2
years) (F = .15.56, df = 3, p = <.001). However, since BCC and KCIW are the tobaccofree prisons these were grouped together to determine if there was a difference between
the two groups of tobacco-free and smoke-free prisons. When the groups were combined,
the mean age of the inmates was not significantly different (F = .78, df = 1, p = .375).
Short-acting inhalers were the most commonly used (72.0%); long-acting inhalers
second most common (20.2%); and oral medications third (7.8%). There were distinct
differences in the proportion of each type of medication by facility with significantly
higher rates of use of inhalers at the tobacco-free prisons (BCC and KCIW) than the
smoke-free (indoors) prisons (EKCC and LSCC). There were significant differences
between the two smoke-free and two tobacco-free prisons for short-acting inhalers (F =
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401.94, df = 1, p < .0001), long-acting inhalers (F = 58.84, df = 1, p < .0001), but not for
oral medications used for asthma and/or COPD (F = 1.03, df = 1, p = .31). Prescribing
differences by the provider were noted particularly with the use of non-formulary drugs
(Advair and Spiriva) at the tobacco-free prisons (BCC and KCIW) with none of those
two at the smoke-free prisons (EKCC and LSCC). Of the oral medications, theophylline
was prescribed more at EKCC than at the other three prisons. Of 259 oral medication
refills, 217 (83.8%) were for theophylline compared to an average of 61.3 dispensed at
the other three prisons over the study period.
Short-acting Inhaler Use after Tobacco-Free Policy Implementation
The final Poisson regression model for short-acting inhalers showed a significant
intervention effect (F= 7.95, df = 101, p = .006). The three-way interaction term of
intervention by month time by facility was not significant (p = .18) and was removed.
Significant two-way interaction effects were observed between intervention*month time
(F =9.90, df = 99, p = .002) and between month time*facility name (F= 7.95, df = 99, p <
.0001). Since the log of the monthly inmate count from KOMS was used as an offset
variable, the model for short-acting inhalers is:
β0

y=e

+ eβ1intervention + e β2facility + e β3month time e β4 month time*facility +

eβ5intervention*month time
A graph of the output from the regression model for short-acting inhalers is
shown in Figure 3.1. At the tobacco-free prisons (BCC and KCIW), the rate of shortacting inhalers was decreasing prior to implementation of the tobacco-free policy
(marked by the dotted vertical lines). The inhaler use dropped in the month after the
policy was implemented but increased gradually back to the level of use prior to policy
implementation within 12 months at BCC and 14 months at KCIW. Inhaler use gradually
increased at EKCC and decreased at LSCC (smoke-free indoors).
Long-acting Inhaler use after Tobacco-Free Policy Implementation
The model for long-acting inhalers was significant with a three-way interaction
effect of intervention by month time by facility (F = 20.59, df = 99, p < .0001). Figure 3.2
displays the results of the regression model for long-acting inhalers with the intervention
effect. At the prisons that became tobacco-free (BCC and KCIW) there were opposite
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effects before and after the tobacco-free policy was implemented. Prior to the
implementation date at BCC, the use of long-acting inhalers was gradually decreasing but
was increasing at KCIW. However, after the policy was implemented, the rate increased
monthly at BCC and decreased at KCIW. Rates of use returned to the rate prior to the
policy date within 7 months at BCC. The rate at KCIW did not return to baseline by the
end of the study period. The two prisons with indoor smoke-free policies (EKCC and
LSCC) also had opposite trends in long-acting inhaler use with gradual increases at
EKCC and decreased use at LSCC.
Oral Medication Use after Tobacco-Free Policy Implementation
Oral medications use was not significantly affected by the tobacco-free policy
implementation (F=0.00, df = 102, p < .99). There was a two-way interaction between
month time and facility (F=6.86, df = 102, p = .0003) in which the rate of use of the
medications changed over time with the rate of use of oral medications decreasing over
the study period at EKCC and LSCC (smoke-free indoors) and increasing at BCC and
KCIW (tobacco-free prisons) (see Figure 3.3).
Discussion
This study was designed to determine the effect of tobacco-free prison policy on
the respiratory health of inmates with asthma and/or COPD. Respiratory health was
measured by the proxy use of short- and long-acting inhalers and oral medications. The
hypothesis that tobacco-free policies would result in improvements in respiratory health
as indicated by decreased use of medications for asthma and/or COPD was partially
supported. There was an immediate effect of the tobacco-free policy on the use of shortterm inhalers such as albuterol and ipratropium within a month after the policy was
implemented. However, the rate of use gradually increased to the level prior to the policy
implementation within 12 to 15 months at the tobacco-free prisons. The rate of refills of
long-acting inhalers had opposite trends before and after implementation of the tobaccofree policy. There was no effect of the policy intervention on the use of oral medications
but there seemed to be a prescribing effect by the primary care providers with differences
in the use of certain medications in the four prisons.
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The results pose more questions than answers about the inconsistent effect of the
tobacco-free policy given that improvements in respiratory health have been seen in the
non-incarcerated population following smoke-free laws in public places and workplaces.
The reasons for this are that inmates may continue to smoke after tobacco-free policies
have been implemented or that the security status of the prison allowed for easier access
to tobacco following policy implementation. Inmates tend to continue smoking after
prisons adopt comprehensive smoke-free policies or tobacco-free policies, with 76% of
male inmates reporting smoking one month after a comprehensive smoke-free policy
(indoors and out) was implemented (Cropsey & Kristeller, 2005b). Inmates in a prison
that had adopted a complete tobacco-free prison policy reported that 42% continued to
smoke compared to 64% in a prison that had an indoor-only tobacco-free restriction
(Proescholdbell, et al., 2008).
The security status of the prisons may affect the use of tobacco and the
enforcement of the policy. Access to tobacco is greatest in minimum security status
prisons according to inmates and officers (Lankenau, 2001). There are fewer restraints
such as barbed wire fences, guard towers and many are more farm-like which gives
inmates the opportunity to obtain tobacco from outside sources or while they are on
work-release in the community. The two tobacco-free prisons in this study were BCC
which is a 500 acre minimum security prison with no fences and KCIW which houses
medium and minimum security inmates. The two tobacco-free prisons (BCC and KCIW)
also differ from the two smoke-free (EKCC and LSCC) prisons by having a more rapid
turnover. BCC is the facility that inmates move to as a step-down from higher security
levels in the year prior to discharge so most are housed there for less than one year.
Women tend to have shorter sentences than men. The influx of new inmates may affect
the medication refill rate as inmates move to tobacco-free prisons from other prisons and,
as a matter of course, get their chronic medications refilled. Inmates who move to these
prisons also may have been smoking and continue to have respiratory symptoms after
entry to a tobacco-free prison.
Enforcement of the smoke-free and tobacco-free policies may have affected the
findings of this study. Implementation effectiveness can affect the current smoking rate
and SHS exposure (Lee, et al., 2009) which could affect respiratory health indicators.
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Enforcement may have been stronger immediately after the policy went into effect and
waned over time given that the use of short-term inhalers decreased significantly in the
few months afterwards and within a year or so was back to the previous level.
Approximately two years after BCC and KCIW became tobacco-free prisons, a study
measuring PM2.5 levels in two dormitories in each of the four prisons used in this study
was conducted (Unpublished, McGuire & Connell, 2010). At BCC (tobacco-free) which
is all minimum security, the maximum PM2.5 was 11.2 µg/m3 in one dormitory and 30.4
µg/m3 in a second. At KCIW (tobacco-free) the maximum level in two dormitories was
4.1 µg/m3 and 15.0 µg/m3. At the two smoke-free prisons (EKCC and LSCC), the highest
level in a medium security dormitory at each prison was 37.5 and 37.1 µg/m3 but was
16.5 and 17.4 µg/m3 in a minimum security dormitory at the same prisons indicating that
there may be variations in enforcement of the policy within prisons which may affect the
respiratory health indicators measured in this study.
The study results indicate that primary care providers such as the physicians and
nurse practitioners need to continue to counsel their patients on tobacco cessation
regardless of the tobacco policy of the prison. In prisons with indoor smoke-free policies,
providers should also encourage current smoking inmates not to smoke indoors to reduce
the exposure to non-smoking inmates. In prisons with tobacco-free policies, providers
should not assume that inmates are not smoking once the policy is implemented.
The main policy implication is that the success of a tobacco-free policy in
reducing the use of tobacco depends on the consistent enforcement of the policy in
dormitories and outside. Most states report that tobacco becomes the most common form
of contraband after a tobacco-free policy is implemented which to many administrators is
better than smuggling heroin (NCCHC, 2004). This presents challenges to correctional
officers who have many other forms of contraband to deal with including cell phones,
knives (shivs), and illicit drugs. A replication of this study in a tobacco-free medium
security prison in which tobacco is harder to smuggle would help to determine the effect
of the looser structure of a minimum security prison on the effect of the policy.
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Limitations
The primary limitation in this study was the lack of longitudinal inmate
movement data which are available in the Kentucky Offender Management System
(KOMS). Longitudinal person-level data that tracks the location of the inmates each
month would allow for calculation of the rate of medication use per inmate with asthma
and/or COPD, as opposed to the rate of medication use per capita in each prison. The
inmate movement is the critical piece of missing data since it was not possible to
determine if an inmate did not refill a medication, whether the inmate had better
asthma/COPD control, or whether he or she had been moved to another prison or was
discharged. The rate of turnover in the prisons was not available to control for the influx
and outflow of inmates. These data may be available from the KY DOC but is more
likely to be aggregated quarterly or yearly rather than daily. Also, in this study, since the
data were obtained from the pharmaceutical vendor, demographics such as race/ethnicity,
co-morbidities, or other medication use was not entered into the model. Smoking status
of the inmates was also not known.
A second limitation is that enforcement was not assessed and air quality was not
measured before and after the tobacco-free policy to document compliance with the
policy. The study using PM2.5 in the four prisons was done two years after the tobaccofree policy was implemented, and pre-policy air quality data are unknown. The best way
to gauge enforcement would be to measure PM2.5 before and at varying time periods after
to assess policy compliance over time.
The third main limitation was that the tobacco-free policy was implemented in the
two prisons with more rapid turnover rates and many if not all, minimum security
inmates (BCC and KCIW) than the smoke-free prisons which were 95% medium security
(EKCC and LSCC). Kentucky State Reformatory (KSR) is a tobacco-free, medium
security prison and the medical facility for the state and has a more stable population with
fewer turnovers due to housing inmates who are more ill. However, medication data were
not available prior to the prison becoming tobacco-free because Diamond
pharmaceuticals did not have the contract with the KY DOC prior to the tobacco-free
policy implementation at KSR.
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Future research is suggested using a prospective study of inmates with a diagnosis
of asthma and/or COPD in Kentucky prisons with varying levels of tobacco-free policy.
These inmates could be assessed for biomarkers of SHS exposure, demographic data and
FEV1 measurements, salivary cotinine levels, personal smoking history and movements
between prisons to control for person-level data and the influx of inmates into and out of
prisons with different tobacco policies. EHR records of provider prescriptions could be
documented as a control variable. These data could be entered in a generalized linear
regression model to determine the effect of the tobacco policy on biological markers of
smoke exposure and lung function.
The optimal time to conduct a policy analysis study on health outcomes is when
an entire state Department of Corrections adopts a tobacco-free policy such as in 2010
when Nevada, Virginia, North Carolina and Georgia become tobacco-free in all prisons
simultaneously. In this setting all inmates receive the same intervention (i.e., tobacco-free
policy) so that the only inmate movement data needed would be the dates of admission
and discharge into and out of the prison system. Month by month tracking would not be
necessary since every prison would have the same policy.
Conclusion
The hypothesis that there would be a reduction in inhaler and oral medication use
after the implementation of a tobacco-free policy in Kentucky state prisons was partially
supported. There was an immediate reduction in use of short-term inhalers following the
tobacco-free date in both of the intervention prisons but the rate gradually increased to
baseline within 12 to 15 months. The turnover of inmates in the two prisons with a
tobacco-free policy is postulated as the most likely reason for this gradual increase in
short-term inhaler use but movement data were not available from the pharmaceutical
vendor. The logistical issues of tracking thousands of inmates over time intervals from
one movement to the other precludes the use of KOMS data unless it were for a smaller
sample.
Given the improvements in respiratory health indicators in the non-incarcerated
population secondary to smoke-free laws in public places and workplaces and the shortterm benefit of the tobacco-free policy in this study, comprehensive tobacco-free prison
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policies may improve the respiratory health of inmates. Enforcement of tobacco-free
policies is the key to implementation effectiveness especially in minimum security
prisons where tobacco may be more readily accessible.
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Table 3.1 Characteristics of accessible population of prisons by policy status
Prison

Average
Inmate
Population

Gender

Security Status

Policy Status

Blackburn
Correctional
Complex (BCC)

594

Male

Minimum

Tobacco-free
prison policy
Sept 17, 2007

Kentucky
Correctional
Institution for
Women (KCIW)

682

Female

Minimum/Medium/
Maximum/Death Row

Tobacco-free,
prison policy
July 1, 2007

Eastern Kentucky
Correctional
Complex (EKCC)

1689

Male

Medium (1639
inmates)

Smoke-free
inside only

Little Sandy
Correctional
Complex (LSCC)

992

Minimum (50 inmates)
Male

Medium (892 inmates)
Minimum(100
inmates)
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Smoke-free
inside only

Table 3.2 Study variables
Variable Name

Coding

Type of Data

Facility Name

Name of prison (BCC, KCIW, EKCC, LSCC)

Nominal

Tobacco policy

‘0’ for smoke-free (indoors)

Nominal

‘1’ for tobacco-free
Month Time

Number of months during the study period starting
Continuous
with July 2006 as ‘1’ to ‘33’ for BCC in March 2009

Age at Fill

Age calculated as the age at the time of refill

Continuous

Inmate Count

Monthly inmate count in each prison from KOMS

Continuous

Short Acting
Inhaler Use

Short-acting inhalers (Albuterol, Ipratropium
bromide)

Nominal

Long Acting
Inhaler Use

Long-acting inhalers (Q-var, Advair, Azmacort,
Spiriva)

Nominal

Oral Medication
Use

Oral (Theophylline, Terbutaline, Singulair,
Accolate)

Nominal
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Table 3.3 Study period dates in each prison
Prison

Study start date

Tobacco-free
date

Study end
date

Number of
months in
study

Blackburn Correctional
Complex (BCC)

July 1, 2006

Sept 17, 2007

March 31,
2009

33

Kentucky Correctional
Institution for Women
(KCIW)

July 1, 2006

July 1, 2007

December
31, 2009

30

Eastern Kentucky
Correctional Complex
(EKCC)

July 1, 2006

NA

December
31, 2009

30

Little Sandy
Correctional Complex
(LSCC)

July 1, 2007

NA

December
31, 2009

13
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Table 3.4 Demographic data by inmate and medications

Demographic data

Tobacco-free
prisons
BCC
KCIW

Total

Total population

Smoke-free (indoor)
prisons
EKCC
LSCC

594

682

1689

992

Total sample of inmates

1109

281

461

240

127

Age Range

19-75

20-75

19-64

20-75

19-75

Age Mean

41.7

45.2

39.2

40.7

41.7

Gender

M/F

Male

Female

Male

Male

Total medications

6374

1898

1622

1905

949

Short-acting inhalers

4587

1437

1220

1313

617

Long-acting inhalers

1289

380

305

333

271

Oral medications

498

81

97

259

61
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Figure 3.1 Short-acting inhalers (MDIs per 1000 inmates per month)
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Figure 3.2 Long-acting inhalers (MDIs per 1000 inmates per month)
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Figure 3.3 Oral medication use (Theophylline, Terbutaline, Singulair, Accolate)
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CHAPTER 4: TOBACCO-FREE PRISON POLICY AND ACUTE MYOCARDIAL
INFARCTION AMONG INMATES
Synopsis
Purpose: The purpose of this study was to determine the effect of a tobacco-free
policy on the hazard of acute myocardial infarctions (AMI) in inmates compared to
inmates in prisons that had indoor smoke-free policies. Smoke-free in the KY DOC
means that there is no smoking indoors but outdoor smoking is allowed. Tobacco-free
means that no tobacco of any kind is allowed on the grounds of the prison.
Hypothesis: It was hypothesized that there would be a lower hazard for having an
AMI in the tobacco-free prisons than the smoke-free (indoors) prisons, where 70% of the
inmates could continue to smoke outside.
Method: The study design was a retrospective survival analysis on the time to first
AMI using censored intervals with tobacco policy status (tobacco-free or smoke-free) of
the prison as the primary predictor variable.
Sample: A list of all inmates (N = 87) who had a hospital discharge diagnosis of
AMI between January 1, 2005 through December 31, 2009 in six state prisons in
Kentucky was obtained from the health care management company for the KY DOC.
Results: The hazard ratio for an AMI for the time inmates were housed in a prison
with an indoor smoke-free policy was 2.87 compared to the time spent in a tobacco-free
environment after controlling for facility, past smoking status, co-morbidities, race and
age.
Conclusions: There is an increased hazard for having an AMI while living in a
prison with an indoor smoke-free policy where smoking is allowed outdoors which may
be a result of current smoking by approximately 70% of inmates and subsequent outdoor
secondhand smoke (SHS) exposure for non-smoking inmates. There is a clear policy
implication for prisons to adopt tobacco-free policies instead of indoor smoke-free
policies to improve the health of inmates.
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TOBACCO-FREE PRISON POLICY AND ACUTE MYOCARDIAL INFARCTIONS
AMONG INMATES
Introduction
Cigarette smoking is the leading cause of death in the United States, causing 21%
of all deaths. Secondhand smoke (SHS) is estimated to cause between 57,800 to 97,700
AMIs annually and between 33,500 and 56,900 deaths from coronary heart disease per
year (Lightwood, et al., 2009; Peto, et al., 2006). SHS has been estimated to cause 80% to
90% as much damage as smoking (Barnoya & Glantz, 2005). Secondhand smoke is
defined by the American Cancer Society (ACS) as a combination of sidestream smoke
which is the smoke from the end of a lit cigarette, cigar or pipe, and mainstream smoke
which is the smoke exhaled by the smoker (ACS, 2010). The 2006 Surgeon General’s
report on “The health consequences of involuntary exposure to tobacco smoke” reviewed
the scientific evidence to date and concluded that there is no risk-free level of exposure to
SHS and that separate smoking areas within a building cannot eliminate SHS (USDHHS,
2006).
Outdoor SHS also produces measurable levels of nicotine in non-smokers. In a
study of 10 non-smokers who spent an average of 25 days at outdoor bars and restaurants
that allowed smoking in Athens, Georgia, salivary cotinine, a nicotine metabolite,
increased by up to 162% from baseline after outdoor SHS exposure (Hall, et al., 2009).
Outside nightclubs in Athens, Greece, the average outdoor level of fine particulate matter
(PM2.5) from the burning end of a cigarette was 32.2µg/m3, exceeding the standard
maximum level set by the Environmental Protection Agency (EPA) of 15 µg/m3 for
annual exposure and is close to the 24-hour standard of 35 µg/m3 (EPA, 2009).
The overall relative risk for coronary heart disease for people who smoke is 1.78
and 1.31 for people exposed to SHS (Barnoya & Glantz, 2005). However there is a dosedependent effect from increasing cigarette exposure as reported in a large international
study, the INTERHEART study which was designed to examine cardiovascular risk
factors for acute myocardial infarction (AMI) including the effects of smoking and
secondhand smoke on the risk for AMI (Teo, et al., 2006). The study enrolled 15,152
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cases of first AMI matched by age and sex with 14,820 controls in 52 countries. The odds
ratio (OR) for AMI increased by 1.056 for every additional cigarette smoked per day so
that a person who smoked 40 cigarettes per day had an OR of 9.16. There was an
increased risk of AMI with increasing hours of SHS. The OR for having an AMI was
1.24 with 1 to 7 hours per week of SHS which increased to 1.62 for people living with a
spouse who smoked or who were exposed over 21 hours per week.
Smoke-free legislation in communities, states, and nations, has resulted in
reductions in the incidence of acute myocardial infarctions (AMI) as concluded by the
Institute of Medicine (IOM) (IOM, 2009). The 2009 IOM report summarized the data on
the incidence of AMI following smoke-free policies in 11 national and international
locales and found that there is sufficient evidence to infer a causal relationship between
SHS and coronary heart disease and that smoke-free policies reduce the risk for AMI.
The first report on the incidence of AMI following enactment of a smoke-free
ordinance was from Helena, Montana in 2002. Over the next six months there was a 40%
reduction in AMIs (Sargent, et al., 2004). A time-series study using the 18 month period
before and after an ordinance was implemented in Pueblo, Colorado found a 27 percent
reduction in AMI hospitalizations in the City of Pueblo and no decrease in the adjacent
county where public smoking was allowed (Bartecchi, et al., 2006). New York State
passed a comprehensive smoke-free policy in 2003. In the following year there were
3813 fewer hospital admissions (8% reduction) for AMI than expected after adjusting for
seasonal and secular trends (Juster, et al., 2007).
Reductions in AMI have also been reported at the national level after countries
have enacted smoke-free policies in indoor public places. The hospitalization rate for
AMIs in a region of Italy decreased by 11% among people less than age 60 after a
prohibition on indoor smoking in public places in 2005 (Barone-Adesi, et al., 2006). In
the 10 months after smoking was prohibited in public places in Scotland, there was a 17%
reduction in the incidence of hospitalizations for AMI compared to a 4% reduction in
England which did not have a smoke-free policy (Pell, et al., 2008). Two meta-analyses
on studies on AMI incidence following smoke-free policies found that there was a 17%
reduction in the rate of hospitalizations for AMI worldwide where smoke-free policies
were enacted (Lightwood & Glantz, 2009; Meyers, et al., 2009). The research is clear that
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smoke-free legislation reduces AMIs but there is no research on the effects of
comprehensive smoke-free (indoors and out) or tobacco-free prison policies on AMIs
among inmate populations.
Tobacco use and policy in United States prisons
In the United States, prison inmates as a sub-population have three times higher
rates of current cigarette smoking than the non-incarcerated population, with current
smoker rates reported from 42% to 91% with an average of 70 to 74% (Cropsey, et al.,
2006; Durrah, 2005). Tobacco related disease is common in inmates. The leading cause
of death in inmates is cardiovascular disease, as it is in the general population, accounting
for 27% of the deaths in state prisons between 2001 and 2004 (Mumola, 2007).
The cost of health care from tobacco-related diseases is a primary reason that
correctional departments have adopted increasingly restrictive tobacco policies. The
Kentucky Department of Corrections (KY DOC) reported that the highest medical cost
by category was for the treatment of diseases of the circulatory system: $3.4 million in
the 10 months from July 1, 2008 to April 30, 2009 (Upton & Spaulding, 2009). The
United States Supreme Court determined that deliberate indifference to inmates’ serious
medical needs constituted an Eighth Amendment violation ("Estelle v. Gamble," 1976),
so that inmates must receive health care which cost $3.3 billion in the 50 state prison
systems in 2001, representing 12% of the total operating cost (Stephan, 2004).
Smoke-free and tobacco-free policies are becoming more prevalent in correctional
systems. By 2004 the majority of state correctional departments and the Federal Bureau
of Prisons had adopted indoor smoke-free policies which allow outdoor smoking only or
limited indoor smoking in designated areas (Zoroya, 2004). Due to the health effects of
cigarette smoking and SHS on health and the cost of providing health care to inmates, in
the past five years more State Departments of Corrections have adopted tobacco-free
policies prohibiting all tobacco products on the prison campus for staff, visitors, or
inmates. With a tobacco-free policy, tobacco is considered contraband in the same
manner as illicit drugs, weapons or cell phones, and may carry a misdemeanor charge in
some states and a felony charge in others such as New York and Texas (Byrne, 2006;
Wilcox, 2007a). Tobacco, however, continues to make its way into prisons and a survey
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by the National Correctional Commission on Health Care (NCCHC) (NCCHC, 2004)
reported that, following a complete tobacco-free policy, tobacco usually overtakes heroin
as the primary smuggled drug.
Air quality studies in prisons have shown that there can be significant reductions
in SHS following tobacco-free policies but enforcement of the policy is a critical factor in
reducing tobacco use. In North Carolina there was a 98% decrease in SHS as measured
by PM2.5 in a dormitory where the level was 305 µg/m3 before a tobacco-free policy and
6.5µg/m3 after the policy was implemented (Proescholdbell, et al., 2008). However,
enforcement of the policy may vary even within prisons. In three Kentucky prisons in
which indoor smoking was prohibited, the highest level of PM2.5 in three medium security
dormitories was more than double that of minimum security dormitories in the same
prisons (McGuire & Connell, 2010).
Health outcome studies on the effects of smoke-free or tobacco-free prison
policies have not been reported in the literature. The purpose of this study was to
determine the effect of a comprehensive tobacco-free policy on the hazard ratio for AMI
in prisons with smoke-free (indoors) policies compared to prisons that had tobacco-free
policies. Tobacco-free in the KY DOC means that no tobacco of any kind is allowed on
the grounds of the prison. Smoke-free in the KY DOC indicates that there is no smoking
indoors but outdoor smoking is allowed. It was hypothesized that there would be a lower
hazard for having an AMI in the tobacco-free prisons than the smoke-free (indoors)
prisons. Approval was obtained from the University of Kentucky Institutional Review
Board and the Commissioner for the KY DOC.
Methods
The study design was a retrospective survival analysis on the time to first AMI
using censored intervals with tobacco policy status (tobacco-free or smoke-free) of the
prison as the primary predictor variable. Data were collected from three sources:
CorrectCare, the KY DOC and the electronic health record (EHR). CorrectCare provided
a list of all inmates from the six study prison sites who had a hospitalization with a
discharge diagnosis of AMI from the time when CorrectCare commenced its contract
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with the KY DOC starting on January 1, 2005 through December 31, 2009. Inmates who
did not have an AMI during this 5-year period were not included in the study sample.
Setting
In 2003 the KY DOC formed a public/private partnership called the Kentucky
Corrections Health Services Network (KCHSN) in order to manage the health care of
inmates in the state prisons and contain costs while at the same time improving quality of
care. The three KCHSN partners are the KY DOC, the University of Kentucky, and
CorrectCare Integrated Health, Inc, a for-profit health management company. KCHSN
implemented a comprehensive electronic health record (EHR) that allows access to the
medical status, history, and medication record of each inmate. Secondary care data refers
to any health care that was received by the inmate while away from the prison and is
tracked by CorrectCare. This includes the cost and related data for hospitalizations and
specialty consults.
There are 16 State prisons in Kentucky, three of which are privately managed.
The overarching policy for the KY DOC is an indoor smoke-free policy in which indoor
smoking is prohibited and outdoor smoking is allowed. Of the 13 state-managed prisons,
four have adopted a tobacco-free policy in which no staff or inmate may have tobacco of
any type on the prison campus. There is also a fifth tobacco-free prison in Kentucky
which housed female inmates but it is one of the privately managed prisons and has a
separate medical company managing the health care of the inmates.
Six Kentucky prisons were chosen as study sites, three of which had tobacco-free
policies and three that had smoke-free (indoors) policies. Kentucky Correctional
Institution for Women (KCIW), Blackburn Correctional Complex (BCC) and Kentucky
State Reformatory (KSR) implemented tobacco-free policies between 2006 and 2007 (see
Table 4.1). The two other tobacco-free prisons in Kentucky were not appropriate for the
study due to one being the assessment center for the KY DOC where inmates stayed for
less than a month on average and the other being a privately managed prison with a
different health care management company. The three tobacco-free prisons used in the
study were fairly unique within the state system, preventing matching prisons by gender
or security status. KCIW is the only female prison that is managed by the KY DOC. BCC
is the only minimum security prison which houses more than 300 inmates so there was
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not a match of equivalent size by security status. KSR is the largest prison in the state and
is comparable in size and security status to EKCC, since both are medium security
prisons with over 1600 inmates. KSR is unique in that it houses inmates who have more
complex medical needs and includes a 58 bed nursing care facility. Three prisons with
indoor smoke-free policies (outdoor smoking allowed) were chosen randomly from the
remaining KY DOC prisons since matching was not possible (see Table 4.1). These three
were Eastern Kentucky Correctional Complex (EKCC), Little Sandy Correctional
Complex (LSCC) and Luther Luckett Correctional Complex (LLCC). Table 4.1 shows
the population and smoking status of each prison. Each of the medium security prisons
houses a few minimum security inmates who live “outside the fence” and do maintenance
work on the property.
To provide information on where the inmates had been housed for at least six
years prior to their first AMI, Kentucky Offender Management System (KOMS) data of
inmate movements from January 1, 1999 through December 31, 2009 was provided by
the KY DOC for each of the inmates who had AMIs. KOMS is a database that contains
demographic data, sentencing information and movement of inmates from prison to
prison or whenever they leave the prison (i.e., for medical appointments, hospitalizations
or court appearances).
Sample
There were 87 inmates from the six prisons during the period from January 1,
2005 through December 31, 2009 who had a hospital discharge diagnosis of AMI (see
Table 4.2). The racial distribution was similar to the Kentucky offender population with
64.5% Caucasian, 27.5% African American and 8% unknown. In 2009, the KY DOC had
a racial distribution of 64% Caucasian, 34% African American and 2% other. Of the 87
inmates who had an AMI, all but one was male. The age range for the sample was 24 to
84 years of age with a mean of 56.4 years (SD = 11.32).
The majority of inmates had at least one co-morbidity of diabetes, hypertension
and/or hyperlipidemia. Seventy-five inmates (86.2%) had hypertension and 71 (81.6%) at
least two co-morbidities. Only five inmates had no diagnosis of hypertension,
hyperlipidemia or diabetes. Data were unavailable for four inmates because the EHR was
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implemented incrementally starting at KSR in June 2005 and the AMI occurred prior to
that time.
KSR is the primary medical facility for the KY DOC and 50.6 of the AMIs
occurred while inmates were living at KSR (n = 44). There were 19 AMIs in the 16
months prior to the tobacco-free date and 25 in the 43 months after the policy was
implemented. EKCC is the second largest prison next to KSR. Inmates who are minimum
security with medical conditions are typically housed at BCC. There were 18 AMIs at
EKCC, 7 at LSCC and 9 at BCC. Six AMIs happened at BCC prior to the tobacco-free
date and three occurred after. Two inmates had AMIs while incarcerated in a jail and a
halfway house. The inmates who had AMIs in the jail and halfway houses are state
inmates but were housed outside of the 13 KY DOC prisons since approximately 7,000 of
the 20,000 KY inmates are housed outside of the state prisons.
The longest stay in one facility was 3,449 days. The majority of inmates moved
from prison to prison multiple times with only 29 (33%) moving less than once a year.
The greatest number of moves for one inmate was seven times in one year and the most
total movements was 24 for one inmate over a 7 year period. The mean number of prison
moves was 1.1 per year for the total sample. There were four inmates who stayed in one
prison for the length of their incarceration during the study period.
Measures
Time to the first AMI was the primary outcome measure. Since this was a
survival analysis, subsequent AMIs were not included in the analysis to avoid duplication
of time intervals. AMI was defined as a hospital discharge diagnosis of ICD-9 codes
410.0 to 410.99. Demographic data such as age, race/ethnicity, co-morbidities, past and
current smoking history were derived from the EHR. Age for each time interval was
calculated as the average age over that time period (‘age during’). Racial data were
derived from the EHR and were not available for all inmates. Co-morbidities of diabetes,
hypertension and hyperlipidemia were elicited from the problem list in the EHR.
A binary variable was created identifying the tobacco policy of the prison during
a particular time interval. The values of the binary indicator variable for smoking policy
were ‘1’ (indoor smoke-free policies in which smoking was allowed outdoors) and ‘0’
(tobacco-free prisons prohibiting all tobacco products on the grounds of the prison).
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Facility data were recorded as KSR, EKCC, LSCC, BCC and Location Other.
Location Other included one AMI at KCIW and eight AMIs that occurred at other
facilities. CorrectCare recorded the prison to which the inmate was discharged on the
billing data and eight of the inmates were discharged from hospital to KSR since it is the
medical facility but had their AMI in other prisons. KOMS inmate movement data were
used to determine where the inmates were residing at the time of their first AMI.
Past smoking was recorded as any report of smoking in the chart from the intake
history, the problem list or the clinical notes. The EHR had documentation that 61
(70.1%) inmates were past smokers, four (4.6%) had never smoked, and 22 (25.3%) had
no smoking history information. Current smoking indicates that at the last entry noted in
the chart, the inmate continued to report that he was smoking. However, after inmates
moved to a tobacco-free prison in which tobacco was completely prohibited, the
providers generally did not ask about smoking history. At the last entry documented in
the EHR there were 49 (56.3%) current smokers and 15 (17.2%) non-smokers, with no
information on 23 (26.4%) but the quit dates for the non-smokers were not documented
in relation to the AMI occurrence so current smoking history was not used in the analysis.
Statistical Analysis
Cox regression, a type of survival analysis using a proportional hazards model
(Garson, 2010), was used to analyze the time to first AMI. This regression analysis is
appropriate for determining the effects of one or more predictor variables on an outcome
that is censored (i.e., it measures time to an event that may not have yet happened for all
observations). Those observations for which the event has not yet occurred are treated as
censored, while those with an event are not censored. In this study, the dependent
variable was time to an inmate’s first AMI. Each observation or time interval was entered
as a censored or not censored interval based on whether the AMI occurred during that
time period. The tobacco policy at each time period was the primary predictor variable.
The hazard ratio is the main statistical output and indicates the likelihood of an event
occurring in a given time period which has associated variables (i.e., tobacco policy
status) compared to another time period that does not have these variables (Garson,
2010). The hazard ratio is a summary of the probability of events per unit time. If there
are many unit-times, there is a greater probability of an event occurring.
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Each time interval had a tobacco-related policy covariate associated with it; this
variable was a binary variable that indicated whether the facility was smoke-free or
tobacco-free. Time intervals were the number of days the particular inmate spent at a
given facility before being moved to another location. KOMS data listed every movement
after 1/1/1999. In some cases in which an inmate had been committed prior to 1999, the
first movement from a particular prison was at some future date, indicating that the
inmate had been housed in that prison since 1/1/1999. The duration of time between
1/1/1999 and the time of the first movement was calculated. Likewise, the last
documented movement may have been years prior to the end of the study period. In these
cases, the date of the last movement until the end of the study period on 12/31/2009 was
calculated as a time interval since this indicated that the person had stayed at that same
prison until 12/31/2009. Each time interval was recorded as days which could last for less
than one day if the person went out and back in a day or potentially up to 4,015 days if
the person stayed in one facility for the entire 11 years.
Some of the time intervals extended over the time when the prisons became
tobacco-free. To account for this situation, the total time period was divided into two time
periods: one before the tobacco-free policy and one time-period after the tobacco-free
policy. Table 4.3 provides an example of one inmate’s movements between facilities over
the study period. The inmate in the example moved to four different prisons between
1/23/2005 and 12/31/2009, the end of the study period. Between 5/12/2005 and
2/14/2008, the inmate resided in KCR which became tobacco-free on 5/1/2006. This time
interval between 5/12/2005 and 2/14/2008 was analyzed as two time periods for this
inmate, namely before and after the tobacco-free date. For prisons that had not yet
become tobacco-free by the conclusion of the study period (12/31/2009), the tobacco-free
date was listed as 1/1/3000 so that any time intervals prior to this date were identified
with a value of 1 for the binary smoking policy variable (i.e., which indicated smoking is
allowed outdoors). For example, the inmate in Table 4.3 had an AMI on 2/14/2008. Thus
for each time interval before this date, the time interval was censored (since the AMI had
not yet occurred) and the time interval when the inmate was hospitalized for the AMI was
not censored. The date of the first AMI was the stop date for calculating censored
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intervals since the survival analysis is designed to determine the time to an event.
Therefore, the next line of movement after the AMI date was deleted.
Race, past smoking status, average age during each time period and comorbidities of diabetes, hypertension and/or hyperlipidemia were entered as covariates.
Facility data were entered with five levels including KSR, EKCC, LSCC, BCC and
Location Other. Two-way interactions were added for policy-smoke by age-during,
policy smoke by facility, policy smoke by past smoker, and policy smoke by race. The
model was weighted by the length of time in days that the person was incarcerated
between 1/1/1999 and 12/31/2009.
Results
Proportional hazards model
The initial proportional hazards model that included the facility tobacco policy
indicator variable, location, age during each interval, past smoker and race had a good fit
with a likelihood ratio that was significant (χ2 =.21.95, df=10, p =.02). The predictor
variable was the tobacco policy of the facility, i.e., smoke-free (indoors) or tobacco-free.
The hazard ratio for having an AMI in prisons with an indoor smoke-free policy where
outdoor smoking was allowed compared to tobacco-free prisons was 3.34. When
inmates’ co-morbidities were added to the model including diabetes, hypertension and
hyperlipidemia, the final model had a better fit with a significant likelihood ratio (χ2 =
36.17, df= 14, p = .001) (see Table 4.4). in the final model, the hazard ratio for having an
AMI while housed in a smoke-free prison compared with tobacco-free facilities was 2.87
(p = .03).
Having been a past smoker had a hazard ratio of 1.28 compared to being a nonsmoker which was not significant (χ2 = 4.62, df=2, p = .10) but was 2.12 for inmates
whose smoking history was unknown compared to past smokers (χ2 = 4.05, df=1, p =.04).
Location was significant for BCC (p = .02) and KSR (p = .004) which had hazard ratios
of 3.56 and 4.72, respectively, compared to Location Other. Race and age during each
interval were not significant predictors of time-to-AMI. None of the two-way interaction
terms were significant including policy smoke*age-during, policy smoke*past smoker,
policy smoke*facility, or policy smoke*race.
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The prisons with the highest hazard ratio were two of the tobacco-free prisons:
KSR which had a hazard ratio of 4.72 and BCC which had hazard ratio of 3.56 compared
to the group of nine prisons in which there was one AMI each. These results were
expected since these two prisons are the medical facilities for medium inmates (KSR) and
minimum inmates (BCC). Inmates with diabetes had an increased hazard for AMI of 1.14
compared to inmates who did not have diabetes (χ2 = 12.31, df=2, p =.002). The comorbidities of hypertension and hyperlipidemia were not significant. After controlling for
the past smoking history of the inmates, co-morbidities and the prison location, there was
2.87 times the hazard for AMI in prisons with indoor smoke-free policies compared to
prisons with tobacco-free policies.
Discussion
This is the first study to demonstrate a significant increase in the probability of an
inmate having an AMI while living in a prison that has an indoor smoke-free policy
where outdoor smoking is allowed than in a tobacco-free prison, after controlling for
location, and inmates’ past smoking, age, race and co-morbidities. The hazard ratio
indicates that for any given period of time the probability of an inmate having an AMI
goes up 2.87 times in prisons with an indoor smoke-free policy compared to prisons that
do not allow tobacco products on the grounds. After controlling for the two medically
intensive prisons (BCC and KSR) which are also prisons that adopted tobacco-free
policies, there was still an effect of the tobacco policy on the hazard for having an AMI.
The results of this study suggest that a tobacco-free policy may be an effective
way to improve the health of inmates by reducing the hazard of having an AMI. This may
be due to reductions in the proportion of current smoking and in SHS exposure by nonsmokers. Indoor smoke-free policies do not limit current smoking except that they have
to wait until the yard opens to smoke. The tobacco-free policy is more likely to reduce
the rate of current smoking and the number of cigarettes smoked since possessing any
tobacco product is a disciplinary violation. In Kentucky prisons, this is a Category III
violation (on a scale from I to VII) (KYDOC, 2010).
Having a known past smoking history was not associated with an increased
hazard of AMI but an unknown smoking history was associated with more than twice the
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hazard (hazard ratio of 2.12, p = .04). Of the 61 (70.1%) inmates who were known past
smokers, nine reported quitting at some point, three had currently unknown smoking
history and 49 were current smokers at the last documentation in the chart. There were 22
(25.3%) inmates whose smoking history was unknown. Based on the increased hazard
ratio for unknown smoking status, it is probable that these inmates were smokers.
Conversely, the fact that nine past smokers quit smoking, probably resulted in there being
a non-significant hazard for past smoking status. There were only four (4.6%) inmates
who had never smoked and who remained non-smokers.
Current smoking status was not entered in the model because it was not possible
to determine the quit date in relation to the AMI. Some inmates had documentation years
after their AMI that they quit when they moved to a tobacco-free prison and a few had
cardiology reports that they quit after having their first AMI. The prison primary care
providers tended to stop asking about smoking history once the prisons became tobaccofree except in one case where the provider noted that the inmate smelled of smoke and
the inmate confirmed that he had smoked. These data point to the need for providers to
continually reinforce the need for inmates to quit smoking and to encourage smoking
inmates to quit regardless of the prison’s tobacco policy. Brief 5-minute interventions by
providers have been reported by smokers to assist in quitting smoking (Fiore, et al.,
2008).
It is unknown if the inmates return to smoking when they move from a tobaccofree prison to a prison with an indoor smoke-free policy that allows outdoor smoking.
Female inmates in the Indiana Department of Corrections were assessed on stage of
change to quit smoking before and after the implementation of a comprehensive smokefree policy in which no lighted tobacco product was allowed in the prisons or in enclosed
outdoor areas (Cropsey & Kristeller, 2003). Four days after the prison became tobaccofree, those who had not considered quitting were more likely to report that they would
resume smoking on release from prison than those who were contemplating quitting
smoking (F = 27.2, p <.001). This persisted one month after the policy was implemented
(F = 21.8, p <.001). In another Indiana DOC study, 188 male inmates were surveyed
before and after the comprehensive smoke-free policy was introduced (Cropsey &
Kristeller, 2005a). One month after smoking was prohibited, 76% of those who were
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smoking at the time of the policy implementation continued to smoke and 24% had quit.
Having greater withdrawal symptoms was correlated with continuing to smoke (F = 7.61,
p <.01). Lankenau (2001) reported that after prisons implemented tobacco-free policies or
very restrictive smoke-free policies in which no indoor or outdoor smoking was allowed,
inmates who continued to smoke reported smoking fewer cigarettes per day.
This study tracked inmates’ movements from prison to prison over the course of
11 years. The majority of inmates moved from prison to prison multiple times with only
29 (33%) moving less than once a year with the majority of these residing at KSR due to
medical needs. On average inmates moved 1.1 times per year but up to seven times in a
year. In a qualitative study of 40 Australian male and female inmates on the role of
tobacco in prison, the movement from prison to prison or to a new unit was reported by
inmates as particularly stressful and more likely to prompt them to smoke (Richmond, et
al., 2009). Given that inmates move multiple times from prison to prison, there is a
greater chance that they may relapse if moved from a tobacco-free prison to a smoke-free
prison.
Since there are variations in the enforcement of tobacco policies within and
among prisons, there might be even greater reductions in the hazard for AMI if tobaccofree policies are enforced consistently. Four of the six prisons in this study were tested for
PM2.5 in Fall 2009 including two tobacco-free prisons (BCC and KCIW) and two smokefree prisons (EKCC and LSCC) (McGuire and Connell, unpublished, 2010). The smokefree (indoors) prisons (EKCC and LSCC) had low levels of PM2.5 (mean 8.1 µg/m3) in the
communal living areas of the medium security dormitories at these prisons until the
inmates’ cell doors were opened when the level increased to 37.3 µg/m3 indicating that
inmates were smoking in their cells during the night. The two smoke-free (indoors)
prisons (EKCC and LSCC) (see Table 4. 1) are predominantly medium security prisons
with one minimum dormitory outside the fence. The minimum dormitories at EKCC and
LSCC had less than half the level of PM2.5 than the medium dormitories “behind the
fence”. An inmate in a medium security prison has little to lose by smoking so may be
more likely to smoke in his or her cell when there is an indoor smoke-free policy in place
whereas an inmate in a minimum security dormitory in a predominantly medium security
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prison might have to return to medium security with many more restrictions if there is a
disciplinary violation.
Variations between dormitories may also indicate differing levels of enforcement
of the policy within the same prison. At BCC, which is a minimum security, tobacco-free
prison, the highest level of PM2.5 was 30.4 µg/m3 in one dormitory and 11.2 µg/m3 in
another. The PM2.5 of 30.4 µg/m3 was measured at 6 AM in a dormitory lobby which had
a central officer’s station. The SHS level could have been from officers smoking on night
shift or officers who allowed inmates to smoke. Inmates in other minimum security
prisons have reported that bringing tobacco into a tobacco-free prison is easier with lower
security levels (Lankenau, 2001). Correctional officers may be lax in writing up
violations which require a lot of paperwork. The friction resulting from enforcing a nosmoking policy in cells may be viewed as not worth the cost. The attitude of the
corrections’ officers toward smoke-free or tobacco-free policies may affect the
enforcement of these policies. In a survey of 321 Vermont DOC employees, those who
smoked were much less receptive to comprehensive indoor and outdoor smoke-free
policies for inmates and/or employees compared to officers who had quit smoking or
never smoked (p <.001) (Carpenter, Hughes, Solomon, & Powell, 2001).
Limitations
The primary limitation of the study was that data from all of the prisons in
Kentucky were not obtained which would have provided a cross-sectional view of the
AMIs over the entire KY DOC population for five years. Originally, the aim was to
compare three prisons with tobacco-free policies to three with smoke-free policies.
However, the hospital billing data from CorrectCare was recorded with the prison that the
inmate was discharged to and not admitted to the hospital from, resulting in 13 locations
in which AMIs occurred. In the future if this study is replicated, all of the AMIs within
the study time period in all of the prisons need to be included.
A limitation that is inherent in prison studies and needs to be accounted for in
future research is that almost all inmates move multiple times over the course of their
incarceration. The multiple movements from smoke-free (indoors) to tobacco-free prisons
or from jail, halfway house or parole back to prison create challenges in evaluating the
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effects of a tobacco-free policy on the risk for an AMI over time. If inmates stayed in one
prison for an extended period of time before and after a tobacco-free policy was
implemented or if all of the prisons adopted a tobacco-free policy on the same date, a
time-series analysis examining the difference in AMI rates pre- and post-policy could be
conducted. However, in reviewing the inmate movements over the previous 11 years of
these 87 inmates who had AMIs, inmates resided in all of the DOC’s 13 prisons plus the
three private prisons. They also spent time out of prison on parole, in jail or in halfway
houses. Counting the 13 DOC prisons, the three private prisons, jails, halfway houses and
parole there were 19 possible locations in which this sample of inmates resided over the
course of the study period. Since moving between prisons has been identified as a
stressor and a trigger for smoking relapse, future research could add a “movement
variable” to account for the number of moves for each inmate.
While the analysis strategy used in this study was able to account for multiple
movements retrospectively, a case-control study of the potential health benefits of
tobacco-free prisons could prospectively enroll a representative random sample of
smoking and non-smoking inmates and follow them through their incarceration in prisons
with varying tobacco policies for an equal period of years to determine the risks for AMI.
It would be optimal to assess salivary cotinine or exhaled carbon monoxide as an accurate
indicator of current tobacco use during multiple time points in the study which has been
validated in other prison studies to confirm abstinence (Cropsey, et al., 2006; Kauffman,
Ferketich, Murray, Bellair, & Wewers, 2010). Air quality testing in multiple dormitories
could be done simultaneously to monitor the enforcement of the policy in each prison. In
states in which a tobacco-free policy is implemented in all state prisons simultaneously, a
time-series analysis strategy could be used to determine the rate of AMIs in the years
before and after the policy was implemented. In this analysis, cases of AMI would be the
unit of analysis.
Another limitation of the study was having only one female inmate with an AMI
which makes the study not generalizable to women. Women in the prison system tend to
be younger than men and have shorter sentences, which may account for the relative
absence of AMI events in females, in addition to the fact that women typically tend to
have cardiac events at an older age.
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Policy Implications
The policy implication is clear: tobacco-free policies in prisons decrease the
hazard for having an AMI. Indoor smoke-free policies place few restrictions on tobacco
access or on current smokers, even if the policy is enforced, since smoking is still
allowed outdoors and non-smokers remain exposed to SHS outdoors. In cells with doors
(as opposed to open dormitories with multiple bunks) it is more difficult to monitor and
enforce an indoor smoke-free policy where smoking is not visible to the correctional
officers and non-smokers may be exposed to SHS in their cellblocks. Tobacco-free
policies are more likely to reduce the rate of current smoking and reduce the number of
cigarettes smoked by those who take the risk to receive contraband, thereby decreasing
SHS by smokers and non-smokers alike. Strict enforcement of a tobacco-free policy is
affected by the security status and the physical layout of the prison (Lankenau, 2001) and
the attitude of the administration and staff (Carpenter, et al., 2001),.
Conclusions
This is the first study to examine the effects of a tobacco-free policy compared to
an indoor smoke-free policy on cardiovascular health. The results demonstrate that for
time spent in a smoke-free prison there is a 2.87 increased hazard for having an AMI
compared to time spent in a tobacco-free prison in which all tobacco products are
prohibited in the entire prison for staff, inmates, and visitors. Inmates in tobacco-free
prisons may still be able to smuggle tobacco into prison but they risk having disciplinary
violations which is a misdemeanor in some states and a felony in others so are more
likely to at least reduce cigarette consumption even if they do not completely quit
smoking.
There are currently 7.3 million people in America who are under some form of
correctional supervision including jails, state and federal prisons, probation and parole
(Glaze & Bonzcar, 2009). This is a large sub-population which has high rates of tobaccouse and consequently high rates of tobacco-related disease. Tobacco-free policies in
prisons may reduce cardiovascular morbidity and mortality. Given the health and cost
benefits of tobacco-free prisons, there is a national trend in correctional systems toward
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adopting tobacco-free policies. The results of this study may accelerate the likelihood that
prisons will adopt tobacco-free policies rather than less restrictive indoor smoke-free
policies.

Copyright © Alison R. Connell
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Table 4.1 Prisons with tobacco-free and smoke-free policies
Prison

Average

Gender

Security Status

Smoking Status

Minimum

Tobacco-free
on Sept 17,
2007

Population
Blackburn
Correctional
Complex (BCC)

594

Male

Kentucky
Correctional
Institution for
Women (KCIW)

682

Female

Minimum/Medium/
Maximum/Death Row

Tobacco-free
on July 1, 2007

Kentucky State
Reformatory (KSR)

2005

Male

Medium (1987 inmates)

Tobacco-free
on May 1, 2006

Eastern Kentucky
Correctional
Complex (EKCC)

1689

Little Sandy
Correctional
Complex (LSCC)

992

Luther Luckett
Correctional
Complex (LLCC)

1073

Minimum (22 inmates)

Male

Medium (1639 inmates)
Minimum (50 inmates)

Male

Medium (892 inmates)
Minimum(100 inmates)

Male

Medium (1029)
Minimum (44)
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Smoke-free—
Outdoor smoke
allowed
Smoke-free—
Outdoor smoke
allowed
Smoke-free—
Outdoor smoke
allowed

Table 4.2 Demographic characteristics of the sample of inmates with AMI (N = 87)
Variable
Race

Gender

Past smoker

Current smoker
at last entry in
chart

Co-morbidities

Prison at which
AMI occurred*

n

Percent

Black

24

27.5%

White

56

64.5%

Unknown

7

8.0%

Male

86

98.9%

Female

1

1.1%

Yes

61

70.1%

No

4

4.6%

Unknown

22

25.3%

Yes

49

56.3%

No

15

17.2%

Unknown

23

26.5%

Diabetes

36

41.4%

Hypertension

75

86.2%

Hyperlipidemia

64

73.6%

One co-morbidity

7

13.8%

Two or more

71

81.6%

KSR

44

50.6%

EKCC

18

20.7%

LSCC

7

8.0%

BCC

9

10.3%

Other

9

10.3%

*KSR-Kentucky State Reformatory, EKCC-Eastern Kentucky Correctional Complex, LSCC-Little Sandy
Correctional Complex, BCC-Blackburn Correctional Complex, “Other” includes: FCDC-Frankfort Career
Development Center, GRCC-Green River Correctional Complex, KCIW-Kentucky Correctional Institution
for Women, KSP-Kentucky State Penitentiary, LAC-Lee Adjustment Center, LLCC-Luther Luckett
Correctional Complex, MAC-Marion Adjustment Center
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Table 4.3 KOMS data of one inmate’s movement and censored intervals with the prisons’
tobacco policy
From

To

Prison

Prison Tobacco
Policy

Censored Interval

1/25/2005 3/8/2005

Jail

Smoke-free

Yes

3/8/2005

RCC

Smoke-free

Yes

4/24/2005 5/12/2005

EKCC Smoke-free

Yes

5/12/2005 2/14/2008

KSR

Tobacco-free policy was implemented on 5/1/06 so this
time period was divided into two intervals with tobacco
policy as the predictor variable as indicated below

5/12/2005 4/30/2006

KSR

Smoke-free

Yes

5/1/2006

2/14/2008

KSR

Tobacco-free on
5/1/2006

Yes

2/14/2008 2/15/2008

KSR

Tobacco-free

No

4/24/2005

AMI Occurred on 2/14/08
2/15/2008 12/31/2009 KSR

Tobacco-free
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Time interval deleted since
post-AMI

Table 4.4 Hazard ratios for predictors of time to first AMI (N = 87)
Variable

χ2

Indoor smoke-free policy (outdoor smoking
allowed)
Age during the intervals

P value

Hazard
ratio

4.57

.03

2.87

2.51

.11

1.00

Caucasian

0.78

.68

1.17

African American

0.33

.56

0.86

BCC

4.96

.03

3.56

KSR

8.23

.004

4.72

EKCC

1.95

.16

1.89

LSCC

1.41

.24

1.91

Past smoker—yes

4.62

.10

1.28

Past smoker—unknown

4.05

.04

2.12

Diabetes

12.31

.002

1.14

Hypertension

0.99

.32

0.66

Hyperlipidemia

.92

.34

1.38

Race

Location

Inmate smoking history

Co-morbidities
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CHAPTER 5: CONCLUSIONS
Summary of Findings
This dissertation was comprised of a literature review and two research studies.
The literature review discussed the evolution of tobacco-free prison policies, the
motivators for implementing increasingly restrictive policies and the unintended
consequences of tobacco-free policies in prisons. Policy outcome studies with the nonincarcerated population were reviewed as the background for the hypothesized effects of
tobacco-free prisons on respiratory and cardiovascular outcomes. The first study
compared the effects of two different types of tobacco policies on respiratory health. Two
prisons had indoor smoke-free policies in which smoking was allowed outdoors. The
other two prisons had tobacco-free policies which prohibited all tobacco products on the
grounds of the prison for staff, inmates and visitors. The second study evaluated the
effects of the time an inmate spent in prisons with an indoor smoke-free policy compared
to prisons with a tobacco-free policy on the hazard for having an AMI.
The literature review of smoke-free and tobacco-free policies revealed that there
is a continuum of tobacco-related policies among and within states. Most states now have
indoor smoke-free policies in which smoking is prohibited indoors with outdoor
designated smoking areas for staff and inmates. Comprehensive smoke-free policies
cover indoor and outdoor areas but tobacco is not entirely prohibited from the prison
grounds. The most restrictive policy is a tobacco-free policy in which no tobacco
products are allowed on the prison grounds for staff, inmates, and visitors.
The primary unintended consequence of tobacco-free policy implementation in
prisons is the smuggling of tobacco into prisons which creates a lucrative black market
for the inmate dealers. Correctional officers sometimes participate in smuggling tobacco
into prisons, lured by the significant profit which undermines security in the prison.
Tobacco historically is the main form of informal currency for inmates in prisons which
make its eradication more challenging.
There are no reports of studies on health outcomes of smoke-free or tobacco-free
policies in prisons. In community-based studies of municipalities, states, and countries,
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there is a large body of evidence indicating that the risk for AMI decreases significantly
in the year following passage of smoke-free legislation in public places with the risk
decreasing even more after three years. Respiratory improvements following smoke-free
laws have also been seen with improvements in respiratory symptoms and in severe
asthma exacerbations.
There are studies in prisons that report a reduction in cigarette smoking following
comprehensive smoke-free and tobacco-free policies, but a surprising proportion continue
to smoke. Secondhand smoke (SHS) as measured by particulate matter 2.5 (PM2.5) has
been shown to decrease following the adoption of a tobacco-free policy. However, the
enforcement of the policy appears to determine the level of secondhand smoke (SHS)
exposure.
The first study in this dissertation was a time-series analysis that examined the use
of inhalers and oral medications by inmates with asthma and/or COPD. Two prisons had
smoke-free (indoors) policies and two had tobacco-free policies. Immediately following
implementation of the tobacco-free policy there was a reduction in short-acting inhalers
such as albuterol. However, the use of these medications gradually increased over the
next year back to the frequency of use prior to policy implementation. Confounders in
this study were the rapid turnover of inmates in the tobacco-free prisons and the security
status of these prisons with many inmates living in minimum security. Inmates in
minimum security prisons have greater access to the outside world and consequently to
cigarettes which are often brought into the prison. Future research on the effects of
tobacco-free policies on respiratory health needs to examine person-level data such as
smoking history, physiologic measurements of respiratory function and SHS exposure
and inmate movement data to track admissions and discharges from each prison.
The second study was a survival analysis to determine the hazard for having an
AMI given differing time intervals in prisons with smoke-free (indoors) and tobacco-free
policies. The results of this study demonstrated that there was a 2.87 times increased
hazard of an inmate having a first AMI in a prison that had an indoor smoke-free policy
compared to a tobacco-free policy. Person-level data including inmates’ co-morbidities,
age, race, past smoking history and movement between prisons, jails, halfway houses and
parole were control variables.
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Diabetes was the only co-morbidity associated with an increased hazard ratio of
1.14 compared to inmates without the diagnosis. Hypertension, hyperlipidemia, age and
race were not significant. Having documentation of being a past-smoker was not
associated but having no documentation in the chart of smoking history had a 2.12 hazard
ratio of AMI which may be an indication of current smoking. Two of the tobacco-free
prisons had 3 to 4 times the hazard for AMI compared to the other prisons but these were
the minimum and medium medical facilities for the state and house the sickest inmates.
After controlling for the past smoking history of the inmates, their medical conditions and
the prison location, there was still 2.87 times the hazard for AMI in prisons with indoor
smoke-free policies compared to tobacco-free prisons.
Limitations of this study were that inmates’ smoking history was not readily
available in the electronic health record (EHR) prevented determining if inmates were
current smokers at the time of their first AMI. The second main limitation was that the
billing data were recorded by the prison the inmate was discharged to and not the prison
in which the AMI occurred which resulted in 13 prisons in which the AMI occurred
rather than the original six. The tobacco policies of all the study prisons were included in
the model. If this study were to be replicated, all of the AMIs from the KY DOC prisons
during the study period would be included to give a cross-sectional view of the entire
state.
These two dissertation studies are the first to report on health outcomes secondary
to tobacco-free prison policies. The AMI study was also the first to incorporate the
multiple movements of an inmate population among prisons within one state. The
movement of inmates between prisons is a major challenge in prison policy outcome
research. In the respiratory study, the results may have been affected by inmates’
movement among prisons but this was not tested since the data were derived from the
pharmaceutical company for the state. It was not feasible to track over 1,100 inmates’
movement over three years. In the AMI study with a smaller samples size (N = 87), the
frequency of inmate movements was calculated by specific time intervals and included in
the model with a predictor variable indicating the tobacco policy of the prison at a point
in time. Most inmates moved from one prison to another an average of once per year but
some moved multiple times in one year.
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Research Implications
Findings from these studies support the need for further research that examines
the effects of the continuum of smoke-free to tobacco-free prison policies on health
outcomes on both inmates and correctional staff. In states such as Kentucky that have
different strengths and scopes of tobacco policies it is more difficult to determine the
effect of the policy on a particular health outcome. If these studies were to be replicated,
all state prisons over the same time period would need to be included and all inmates’
movements tracked over an extended time period before and after policy implementation.
Future research would also include a movement variable to account for the number of
movements by each inmate during the study period. The best time to evaluate the effect
of a tobacco-free policy is when an entire state increases the strength and scope of the
existing tobacco policy such as in Nevada, North Carolina, Virginia and Georgia which
are all becoming tobacco-free in 2010. States such as Kentucky where tobacco policies
vary prison by prison make it harder to evaluate the effect of the policy since inmates
move frequently from one prison to another.
There are three main methods for evaluating the effect of tobacco-related policies
on the health of inmates. One is a population-based analysis of a particular health
outcome such as the cases of AMI in the year before and after the implementation of a
tobacco-free policy in all prisons across the state. This would be more challenging if the
policy was not implemented simultaneously on the same date in all prisons. This method
would be similar to studies in the non-incarcerated population in Helena, Montana and
Piedmont, Italy in which the age-adjusted incidence rate in the pre-policy period was
compared to that of the post-policy period (Barone-Adesi, et al., 2006; Sargent, et al.,
2004).
The second method would be a prospective, longitudinal study with a pre-post
design but with a smaller convenience sample that includes person-level data such as
physiologic measures such as cotinine levels and pulmonary function tests, comorbidities, smoking history, length of incarceration and sentencing data, and movement
among, and in and out of prisons. These would be measured preferably for at least a year
prior to the tobacco-free date and then at intervals in the post-policy implementation
period. The health outcome could be the number of cases (e.g., AMI) or a physiologic
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marker (e.g., FEV1) which could be entered into a regression to determine the likelihood
of the particular health outcome while controlling for facility and person-level variables.
A third way of analyzing the effect of tobacco policies on health outcomes in
prisons would be a cost-analysis on AMIs for a period of time. Again, simultaneous
adoption of a tobacco-free policy in all state prisons would be the best scenario for this
analysis. Cost-analysis requires a complex mixed-model design that includes random and
fixed effects such as facility, rate of admissions and discharges to the state, inflationary
costs, and fixed costs such as for staff and overhead.
Practice Implications
The main factor that facilitated the two health outcome studies of the tobacco
policies in Kentucky was the partnership between the KY DOC and the University of
Kentucky: Kentucky Corrections Health Services Network (KCHSN). KCHSN
streamlined and centralized the health care of the inmates in Kentucky by hiring a health
care management company and a single pharmaceutical company. The health care
management company provided the data for the AMI events, and the pharmaceutical
company provided the data on medications by disease type. Both of these companies
have a sophisticated, electronic database which can track data by time, inmate, and ICD-9
code. The electronic health record facilitated chart review since every inmate in the state
has a health chart. Prior to this, each prison contracted with individual and primarily local
vendors and paper charts were used, both of which precluded systematic policy analysis
research. There are few State Departments of Corrections that have a university
partnership but this is recommended to increase the quantity and quality of health-related
research on the incarcerated population since at any given time there are over 7 million
people under correctional supervision including 2.3 million people in prison and
approximately 5 million on parole and probation (Glaze & Bonzcar, 2009).
The most important practice implication of the studies reported here is that
primary care providers need to regularly assess and document details of inmates’
smoking history. This allows for tracking of the quit date in relation to health outcomes.
Providers need to encourage inmates to consider permanent smoking cessation regardless
of the tobacco policy of the particular prison since the literature indicates that inmates
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continue to find ways to smoke even in tobacco-free prisons and they tend to resume
smoking after discharge from a tobacco-free prison (Thibodeau, Jorenby, Seal, Kim, &
Sosman, 2010). Ninety-five percent of inmates will eventually be discharged and many
return to smoking upon return to their home communities (Sabol, et al., 2009; Thibodeau,
et al., 2010). Incarceration may be a time when inmates can achieve prolonged abstinence
from tobacco.
Tobacco dependence treatment needs to be offered to inmates regardless of the
tobacco policy of the prison since approximately 70% of inmates are current smokers on
entry to prison. Tobacco cessation classes have been offered to inmates with varying
degrees of success. A tobacco cessation program, using a mood management training
behavioral intervention once a week for 10 weeks combined with nicotine replacement,
was provided to a purposive sample of 250 female current smoking inmates (Cropsey et
al., 2008). Of the 116 who completed the intervention, quit rates were 18% at the end of
the program, 17% at three months and 14% at six months which is consistent with quit
rates in community cessation programs. In Australia, in a prison with 330 male inmates,
30 signed up for a smoking cessation intervention which included two brief cognitive
behavioral therapy sessions, nicotine replacement gum, bupropion and self-help
resources. At six months, eight (26%) were abstinent which was confirmed by exhaled
carbon monoxide measurements.
Despite promising results of tobacco treatment in prisons, a survey of 100
correctional administrators reported that tobacco cessation programming is not a high
priority in correctional facilities (NCCHC, 2004). Eighty percent reported that they have
no tobacco cessation programs in prisons regardless of the status of the tobacco policy of
the environment. It is recommended that prison health care providers such as physicians,
nurse practitioners and nurses offer tobacco dependence treatment as they would for any
other chronic, relapsing health condition (Fiore, et al., 2008).
Policy Implications
The results of the AMI study reporting a hazard ratio of 2.87 for having an AMI
in a smoke-free prison compared to completely tobacco-free prisons has significant
policy implications for State Departments of Corrections that are considering becoming
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tobacco-free (vs. smoke-free) and for prisons within Kentucky that have not yet become
tobacco-free. Since current smoking prevalence data were not available, it is not clear
whether the reduction in hazard at tobacco-free prisons was related to reductions in
personal smoking, SHS exposure or a combination of the two. Regardless, the policy was
associated with reductions in the hazard of AMI despite expected differences in levels of
enforcement in the prisons and after controlling for unique characteristics of the prisons.
The result of this study will be shared with the Medical Director for the KY DOC and the
Commissioner of the KY DOC as well as with individual wardens of Kentucky prisons
who may consider strengthening the existing indoor smoke-free policies to tobacco-free
prison policies.
Conclusion
This dissertation is the first study to examine health outcomes following adoption
of a tobacco-free policy in prisons. The first study which examined medications for
asthma and/or COPD as a proxy marker of respiratory health did not yield conclusive
results on the effect of the policy. There was an immediate reduction in short-acting
inhaler use for respiratory symptoms but this effect was not sustained over the following
18 months. However, the study with AMIs as the dependent censoring variable in a
survival analysis which included person-level data, determined that there was a hazard
ratio for having an AMI of 2.87 in prisons with an indoor smoke-free policy compared to
prisons with a tobacco-free policy, in which no tobacco is allowed on the grounds of the
prison. These results are consistent with policy outcome studies in the non-incarcerated
population that show reductions in the risk for AMI after passage of smoke-free
legislation. There are no equivalent, free-world studies of tobacco-free policies since nonincarcerated current smokers are at liberty to smoke when away from the location
covered by the law without fear of disciplinary action while inmates risk disciplinary
violations by possessing or using tobacco in tobacco-free prisons.
Tobacco in prisons has an added dimension in that inmates consider it as informal
currency. This increases its demand and value as smuggled contraband after prisons
become tobacco-free. In prisons with comprehensive tobacco-free policies, the rate of
current smoking decreases as the policy becomes more restrictive and as the security
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status of the prison increases. Tobacco typically overtakes heroin as the number one
contraband item following a tobacco-free policy (Garland, 2006) but as one Kentucky
warden who implemented a tobacco-free policy in her prison said, “I would rather chase
tobacco than drugs any day. It’s fiscally and ethically the right thing to do” (personal
correspondence, Warden Crews, June 22, 2010).

Copyright © Alison R. Connell
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